,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,11,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-18 Non-Small Cell Lung cell line,Confirmatory,,
6,13,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
7,15,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
8,19,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
9,21,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
10,23,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
11,27,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the M19-MEL Melanoma cell line,Confirmatory,,
12,29,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
13,31,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line,Confirmatory,,
14,33,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
15,35,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
16,37,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
17,39,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
18,45,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
19,47,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
20,49,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
21,51,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the XF 498 Central Nervous System cell line,Confirmatory,,
22,53,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
23,55,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
24,57,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-78 Central Nervous System cell line,Confirmatory,,
25,59,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
26,61,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 273 Small Cell Lung cell line,Confirmatory,,
27,63,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DMS 114 Small Cell Lung cell line,Confirmatory,,
28,65,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
29,67,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
30,69,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the DLD-1 Colon cell line,Confirmatory,,
31,71,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
32,73,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
33,75,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM20L2 Colon cell line,Confirmatory,,
34,77,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
35,79,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
36,81,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
37,83,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
38,93,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
39,99,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
40,101,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
41,103,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line,Confirmatory,,
42,105,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
43,107,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
44,109,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
45,111,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the P388 Leukemia cell line,Confirmatory,,
46,113,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
47,117,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the P388/ADR Leukemia cell line,Confirmatory,,
48,119,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
49,121,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
50,123,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
51,125,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
52,127,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12K1 Renal cell line,Confirmatory,,
53,129,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the A498 Renal cell line,Confirmatory,,
54,131,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
55,133,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line,Confirmatory,,
56,143,1,1,,114695,3213,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
57,145,1,1,,114695,3213,Active,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
58,155,1,1,,114695,3213,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
59,157,1,1,,114695,3213,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
60,161,1,1,,114695,3213,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
61,165,1,1,,114695,3213,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
62,167,1,1,,114695,3213,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
63,175,1,1,,114695,3213,Active,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
64,182,1,1,,114695,3213,Inactive,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 06 and 41 (intraperitoneal) in B6D2F1 (BDF1) mice",Other,,
65,184,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  ADJ-PC-6 (intraperitoneal) in BALB/cJ mice,Other,,
66,186,1,1,,114695,3213,Unspecified,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Nontumored Animals (Toxicity Test) in B6D2F1 (BDF1) mice,Other,,
67,190,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lymphoma AKR (Transplanted) (intraperitoneal) in AKR/Lw mice,Other,,
68,192,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
69,194,1,1,,114695,3213,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
70,196,1,1,,114695,3213,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intracerebral) in B6D2F1 (BDF1) mice,Other,,
71,200,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  B16 Melanoma (intraperitoneal) in B6C3F1 mice,Other,,
72,206,1,1,,114695,3213,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  HT29;CX-1 Human Adenocarcinoma (MER+) (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
73,210,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon 26 Adenocarcinoma (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
74,212,1,1,,114695,3213,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Colon Carcinoma 38 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
75,222,1,1,,114695,3213,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in C57BL/6 mice,Other,,
76,226,1,1,,114695,3213,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Ependymoblastoma (intracerebral) in B6C3F1 mice,Other,,
77,248,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
78,250,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
79,256,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
80,260,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intracerebral) in CD2F1 (CDF1) mice,Other,,
81,264,1,1,,114695,3213,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Lung LX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
82,270,1,1,,114695,3213,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
83,272,1,1,,114695,3213,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intramuscular) in B6D2F1 (BDF1) mice,Other,,
84,274,1,1,,114695,3213,Inconclusive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Lewis Lung Carcinoma (intravenous) in B6D2F1 (BDF1) mice,Other,,
85,286,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
86,288,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Sarcoma M5076 (subcutaneous) in B6D2F1 (BDF1) mice,Other,,
87,296,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Human Mammary Carcinoma MX-1 Xenograft (intrarenal inoculation) in NU/NU Swiss (nude) mice,Other,,
88,300,1,1,,114695,3213,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  Madison 109 Lung Carcinoma (intramuscular) in unknown mice,Other,,
89,322,1,1,,114695,3213,Active,,,,,"NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Adriamycin; NSC 123127, Developed at Scr 08 (intraperitoneal) in CD2F1 (CDF1) mice",Other,,
90,324,1,1,,114695,3213,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to AMSA; NSC 249992 (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
91,326,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Dihydroxy Anthracenedione; NSC 299195 (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
92,328,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
93,330,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice,Other,,
94,336,1,1,,114695,3213,Active,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia resistant to Vincristine; NSC 67574 (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
95,357,2,1,,855686,3213,Inconclusive,,,,,AP1 Signaling Pathway,Confirmatory,,
96,357,2,1,,11111146,3213,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
97,357,2,1,,11111147,3213,Inconclusive,,,,,AP1 Signaling Pathway,Confirmatory,,
98,361,1,2,,855686,3213,Inconclusive,285623.0,,,,Pyruvate Kinase,Confirmatory,,
99,364,1,3,,855686,3213,Inactive,,,,,Cell Proliferation & Viability (Cytotoxicity) Assay,Confirmatory,,
100,368,2,3,,855686,3213,Inactive,4757950.0,994.0,,,Cdc25B Catalytic Domain protein tyrosine phosphatase  HTS,Screening,,
101,371,1,1,,855686,3213,Active,,,,,Human A549 Lung Tumor Cell Growth Inhibition Assay,Screening,,
102,373,1,4,,855686,3213,Inactive,38788193.0,1903.0,,,S1P3 Agonist Primary HTS and Confirmation Assays,Screening,,
103,374,2,3,,855686,3213,Inactive,4758204.0,1843.0,,,In vitro Primary HTS Assay for MKP-1,Screening,,
104,375,2,3,,855686,3213,Inactive,90108679.0,,,,Mycobacterium tuberculosis Pantothenate Synthetase Assay,Confirmatory,,
105,377,1,3,,10321294,3213,Active,42741659.0,5243.0,,,MDR-1,Other,,
106,382,1,4,,10319000,3213,Active,206729857.0,1195.0,,,"Compound Screen Assay, Human CLK1",Other,,
107,383,1,3,,10319000,3213,Active,153791372.0,1198.0,,,"Compound Screen Assay, Human CLK3",Other,,
108,393,1,2,,10319000,3213,Active,4505811.0,5292.0,,,"Compound Screen Assay, Human PIM1",Other,,
109,410,1,5,,11111146,3213,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
110,410,1,5,,11111147,3213,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
111,411,2,1,,855686,3213,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
112,411,2,1,,11111146,3213,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
113,411,2,1,,11111147,3213,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
114,422,1,5,,855686,3213,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
115,422,1,5,,17405094,3213,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
116,425,3,2,,855686,3213,Inactive,16758752.0,116663.0,,IC50,MKP-3 in vitro HTS assay,Confirmatory,,
117,429,1,5,,855686,3213,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
118,429,1,5,,855686,3213,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
119,429,1,5,,17405094,3213,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
120,429,1,5,,17405094,3213,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
121,430,2,4,,855686,3213,Active,,,6.17,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells),Confirmatory,,
122,431,2,4,,855686,3213,Active,,,2.4,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells),Confirmatory,,
123,432,2,4,,855686,3213,Inactive,11024684.0,12044.0,,IC50,HTS discovery of chemical inhibitors of anti-apoptotic protein Bfl-1,Confirmatory,,
124,436,2,1,,855686,3213,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
125,436,2,1,,17405094,3213,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
126,438,1,4,,855686,3213,Inactive,223468676.0,5970.0,,,Cellular assay for TNF alpha induced NFkappaB translocation,Screening,,
127,440,3,3,,855686,3213,Inconclusive,4503779.0,2357.0,,,Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands,Screening,,
128,441,3,3,,855686,3213,Inactive,54112388.0,2358.0,,,Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands,Screening,,
129,444,1,1,,855686,3213,Inconclusive,,,,,NFAT Signaling Pathway,Confirmatory,,
130,444,1,1,,11111146,3213,Inconclusive,,,,,NFAT Signaling Pathway,Confirmatory,,
131,444,1,1,,11111147,3213,Inconclusive,,,,,NFAT Signaling Pathway,Confirmatory,,
132,445,3,1,,11111146,3213,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
133,445,3,1,,11111147,3213,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
134,446,1,1,,855686,3213,Active,,,,,Stat Signaling Pathway,Confirmatory,,
135,446,1,1,,11111146,3213,Inconclusive,,,,,Stat Signaling Pathway,Confirmatory,,
136,446,1,1,,11111147,3213,Active,,,,,Stat Signaling Pathway,Confirmatory,,
137,447,1,1,,11111146,3213,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
138,447,1,1,,11111147,3213,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
139,448,1,2,,11111146,3213,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
140,448,1,2,,11111147,3213,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
141,449,1,5,,855686,3213,Inactive,13027636.0,1901.0,,,Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators,Screening,,
142,450,1,2,,855686,3213,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
143,450,1,2,,11111146,3213,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
144,450,1,2,,11111147,3213,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
145,451,1,2,,11111146,3213,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
146,451,1,2,,11111147,3213,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
147,454,1,7,,855686,3213,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
148,455,1,7,,855686,3213,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression,Screening,,
149,456,1,7,,855686,3213,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
150,457,1,7,,855686,3213,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression.,Screening,,
151,460,2,2,,855686,3213,Inactive,4503155.0,1514.0,,,Cathepsin L,Screening,,
152,483,1,6,,855686,3213,Inactive,296434520.0,3064.0,,,Aggregation and Clearance of Mutant Huntingtin Protein,Screening,,
153,485,1,8,,855686,3213,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
154,487,1,2,,855686,3213,Inactive,,,,,TNFalpha Induced E-Selectin Expression -  Primary screen,Screening,,
155,488,2,1,,855686,3213,Inactive,63102437.0,1508.0,,,Cathepsin B compound mixture screening,Screening,,
156,501,2,2,,855686,3213,Inactive,23110962.0,1520.0,,,Cathepsin S,Screening,,
157,505,1,2,,10319000,3213,Active,42821112.0,11040.0,,,"Compound Screen Assay, Human PIM2",Screening,,
158,515,1,2,,10319000,3213,Active,5174547.0,4217.0,,,"Compound Screen Assay, Human MAP3K5",Screening,,
159,518,2,6,,855686,3213,Inactive,116734717.0,249.0,,IC50,TNAP luminescent HTS assay,Confirmatory,,
160,521,2,5,,855686,3213,Inactive,18375660.0,5778.0,,IC50,"HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target",Confirmatory,,
161,522,1,2,,855686,3213,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
162,524,1,3,,855686,3213,Active,4506055.0,5566.0,,,Primary biochemical high-throughput screening assay for inhibitors of protein kinase A (PKA) activity,Screening,,
163,525,1,3,,855686,3213,Active,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
164,526,1,1,,11111146,3213,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
165,526,1,1,,11111147,3213,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
166,527,3,1,,855686,3213,Inactive,,,,,Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing,Screening,,
167,528,1,4,,855686,3213,Inconclusive,67191027.0,3676.0,,,Allosteric Agonists for the VLA-4 Integrin,Screening,,
168,529,1,4,,855686,3213,Inconclusive,67191027.0,3676.0,,,Allosteric Antagonists for the VLA-4 Integrin,Screening,,
169,530,1,1,,11111146,3213,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
170,530,1,1,,11111147,3213,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
171,538,2,2,,855686,3213,Inactive,4502495.0,716.0,,,Complement factor C1s,Screening,,
172,539,1,2,,855686,3213,Inactive,116077694.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK,Screening,,
173,547,1,4,,17405094,3213,Inactive,16130533.0,947097.0,,,HTS for inhibitors of bacterial DnaK,Other,,
174,548,1,3,,855686,3213,Active,4506055.0,5566.0,,,Dose-response biochemical assay for inhibitors of protein kinase A (PKA) activity,Confirmatory,,
175,550,1,3,,855686,3213,Active,116515775.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC Dose Response,Confirmatory,,
176,552,1,3,,855686,3213,Inactive,,,,,Antimicrobial HTS Assay for E. coli BW25113 (wild type),Screening,,
177,555,1,2,,855686,3213,Inactive,116516899.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK,Screening,,
178,556,1,3,,855686,3213,Active,116076351.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC,Screening,,
179,559,2,2,,855686,3213,Inactive,147728.0,,,,RNA polymerase,Screening,,
180,560,1,2,,855686,3213,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
181,561,1,3,,855686,3213,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
182,565,1,4,,855686,3213,Inactive,1431733.0,,,,HIV-1 RT-RNase H  MLSCN HTS MH077605,Screening,,
183,567,1,4,,855686,3213,Inactive,55956923.0,3350.0,,,Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) agonists,Screening,,
184,570,1,4,,855686,3213,Inactive,4505209.0,4322.0,,,Primary biochemical high-throughput screening assay for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
185,571,1,4,,855686,3213,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
186,572,1,5,,855686,3213,Inconclusive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay (Pilot Screen),Screening,,
187,573,1,4,,855686,3213,Inactive,,,,,Primary Antimicrobial Assay for E. coli BW25113 &#8710;tolC::kan Protocol for 384-well HTS,Screening,,
188,574,1,3,,855686,3213,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
189,575,1,4,,855686,3213,Active,,,,,Human Endothelial Cell Proliferation Assay,Screening,,
190,576,1,2,,855686,3213,Inconclusive,67191027.0,3676.0,,,Auto-fluorescence of compounds effecting screening of VLA-4 Integrin,Other,,
191,577,1,1,,855686,3213,Inactive,11528014.0,912267.0,,,HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase,Screening,,
192,580,1,5,,855686,3213,Inconclusive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay,Screening,,
193,581,2,2,,855686,3213,Inactive,15680217.0,1511.0,,,Cathepsin G,Screening,,
194,584,1,3,,11111146,3213,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
195,584,1,3,,11111147,3213,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
196,585,1,4,,11111146,3213,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
197,585,1,4,,11111147,3213,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
198,587,1,5,,855686,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
199,587,1,5,,11111146,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
200,587,1,5,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
201,588,1,4,,855686,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
202,588,1,4,,11111146,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
203,588,1,4,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
204,589,1,3,,855686,3213,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
205,589,1,3,,11111146,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
206,589,1,3,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
207,590,1,3,,855686,3213,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
208,590,1,3,,11111146,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
209,590,1,3,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
210,591,1,4,,855686,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
211,591,1,4,,11111146,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
212,591,1,4,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
213,592,1,6,,855686,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
214,592,1,6,,11111146,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
215,592,1,6,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
216,593,1,4,,855686,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
217,593,1,4,,11111146,3213,Active,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
218,593,1,4,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
219,594,1,4,,855686,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
220,594,1,4,,11111146,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
221,594,1,4,,11111147,3213,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
222,595,1,3,,11111146,3213,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
223,595,1,3,,11111147,3213,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
224,596,1,2,,11111146,3213,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
225,596,1,2,,11111147,3213,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
226,597,1,3,,855686,3213,Active,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
227,597,1,3,,11111146,3213,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
228,597,1,3,,11111147,3213,Inconclusive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
229,599,1,2,,855686,3213,Inactive,548814.0,6095.0,,,Counterscreen for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1): A cell-based dose-response assay for inhibition of the RAR-related orphan receptor A (RORA),Confirmatory,,
230,600,2,1,,855686,3213,Inactive,20070193.0,2516.0,,,Dose-response cell-based assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Confirmatory,,
231,601,1,4,,855686,3213,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance Pilot Screen,Screening,,
232,603,1,2,,11111146,3213,Active,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
233,603,1,2,,11111147,3213,Active,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
234,604,1,3,,855686,3213,Active,41872583.0,9475.0,,,Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2),Screening,,
235,605,1,2,,11111146,3213,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
236,605,1,2,,11111147,3213,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
237,606,1,3,,855686,3213,Inactive,224586929.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
238,606,1,3,,855686,3213,Inactive,301171662.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
239,607,1,3,,11111146,3213,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
240,607,1,3,,11111147,3213,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
241,609,1,2,,855686,3213,Inactive,,,,,Chemical Complementation Assay for MKP-3,Screening,,
242,614,1,6,,855686,3213,Inactive,116734717.0,249.0,,,HTS colorimetric detection of phosphate released in TNAP reaction,Screening,,
243,615,1,6,,855686,3213,Inactive,116734717.0,249.0,,,HTS colorimetric detection of p-nitrophenol released in TNAP reaction,Screening,,
244,622,1,2,,855686,3213,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Negative Modulator Primary Screen,Screening,,
245,623,1,3,,855686,3213,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Positive Modulator: Primary Screen,Screening,,
246,624,1,2,,855686,3213,Active,,,,,Measurement of GPCR-mediated thallium flux through GIRK channels: Primary Screen,Screening,,
247,625,1,2,,855686,3213,Active,,,,,Discovery of Novel Allosteric Agonists of the M4 Muscarinic Receptor: Primary Screen,Screening,,
248,626,1,3,,855686,3213,Active,,,,,Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist  Primary Screen,Screening,,
249,628,2,4,,855686,3213,Inactive,113121.0,25229.0,,,Discovery of novel allosteric modulators of the M1 muscarinic receptor: Antagonist Primary Screen,Screening,,
250,631,1,4,,855686,3213,Active,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
251,631,1,4,,855686,3213,Active,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
252,636,1,4,,855686,3213,Inactive,,,,,Modulators of Post-Golgi Transport - 384-well pilot screen,Screening,,
253,637,1,4,,855686,3213,Inactive,,,,,Modulators of Post-Golgi Transport - 1536-well pilot screen,Screening,,
254,641,1,4,,855686,3213,Inactive,,,,,Allosteric Modulators of D1 Receptors: Primary Screen,Screening,,
255,643,1,3,,855686,3213,Active,6680940.0,12672.0,,,Discovery of Novel Allosteric Agonists of the M4 Muscarinic Receptor: Confirmation Screen,Other,,
256,644,2,1,,855686,3213,Active,41872583.0,9475.0,,,Dose-response biochemical assay of inhibitors of Rho kinase 2 (Rock2),Confirmatory,,
257,645,1,4,,855686,3213,Inactive,,,,,Isolation of Inhibitors of Her-Kinase Expression - 66K library screen,Screening,,
258,662,1,1,,11111146,3213,Active,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
259,662,1,1,,11111147,3213,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
260,680,1,10,,855686,3213,Inactive,180352.0,,,,Factor XIa Mixture HTS,Screening,,
261,684,1,12,,855686,3213,Inactive,317373446.0,2161.0,,,Factor XIIa Mixture HTS,Screening,,
262,694,1,1,,17405094,3213,Inactive,118764400.0,2099.0,,,HTS of LOPAC library for Estrogen Receptor-alpha Coactivator Binding inhibitors,Confirmatory,,
263,708,1,4,,855686,3213,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Absorbance at 340 nm,Screening,,
264,709,1,2,,855686,3213,Active,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm,Screening,,
265,731,1,5,,855686,3213,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
266,731,1,5,,855686,3213,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
267,732,1,2,,17405094,3213,Inactive,,,,,In Vivo Angiogenesis Assay for HTS,Screening,,
268,734,1,2,,855686,3213,Inactive,4505209.0,4322.0,,,Assay to identify inhibitors among the possible fluorescent artifacts from the primary HTS inhibition assay of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
269,746,1,1,,855686,3213,Inactive,2507196.0,5602.0,,,Primary biochemical high-throughput screening assay for inhibitors of the c-Jun N-Terminal Kinase 3 (JNK3),Screening,,
270,751,1,3,,855686,3213,Inactive,,,,,Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent),Screening,,
271,757,1,4,,855686,3213,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
272,758,1,4,,855686,3213,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
273,759,1,4,,855686,3213,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
274,760,1,4,,855686,3213,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
275,761,1,4,,855686,3213,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
276,764,1,4,,855686,3213,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
277,770,1,1,,855686,3213,Active,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (24 Hour Treatment Protocol),Screening,,
278,771,1,2,,855686,3213,Active,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (48 Hour Treatment Protocol),Screening,,
279,772,1,2,,855686,3213,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (72 Hour Treatment Protocol),Screening,,
280,774,1,2,,855686,3213,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Inhibition of Enzymes Frequently Used to reach a NAD/NADH Endpoint,Other,,
281,775,1,3,,855686,3213,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
282,780,1,3,,855686,3213,Active,,,,,Measurement of GPCR-mediated thallium flux through GIRK channels: Confirmation Screen,Other,,
283,781,1,1,,855686,3213,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
284,782,1,2,,855686,3213,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
285,782,1,2,,855686,3213,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
286,784,1,4,,855686,3213,Inactive,55584151.0,2629.0,,,Primary Cell Based High Throughput Screening Assay for Enhancers of Beta-Glucosidase Activity,Screening,,
287,793,1,2,,855686,3213,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
288,795,1,1,,855686,3213,Inactive,,,,,MLSCN Assay for Activators of Prostate Cell Differentiation,Screening,,
289,797,1,1,,855686,3213,Active,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
290,798,2,12,,855686,3213,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
291,799,1,5,,855686,3213,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
292,800,2,11,,855686,3213,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
293,803,1,4,,855686,3213,Active,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
294,804,1,3,,855686,3213,Active,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
295,813,1,4,,855686,3213,Inactive,116734717.0,249.0,,,HTS identification of compounds activating TNAP at intermediate concentration of phosphate acceptor detected in luminescent assay,Screening,,
296,817,1,1,,855686,3213,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
297,818,1,2,,855686,3213,Active,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
298,827,1,2,,855686,3213,Active,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
299,828,1,5,,855686,3213,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
300,841,1,1,,855686,3213,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
301,847,1,2,,855686,3213,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay,Screening,,
302,861,1,1,,855686,3213,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
303,862,1,2,,855686,3213,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
304,864,1,1,,855686,3213,Active,6016094.0,8811.0,,,Confirmatory cell-based high-throughput screening assay to identify agonists of galanin receptor 2 (GALR2),Screening,,
305,865,1,1,,855686,3213,Inactive,6016094.0,8811.0,,,Counterscreen for agonists of galanin receptor 2 (GalR2): a cell-based high-throughput screening assay for activators of beta-lactamase activity,Screening,,
306,868,1,3,,855686,3213,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
307,871,1,2,,855686,3213,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
308,873,1,13,,855686,3213,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
309,875,1,2,,855686,3213,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
310,875,1,2,,11111147,3213,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
311,878,1,2,,855686,3213,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
312,879,1,2,,855686,3213,Inactive,3290016.0,6002.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
313,879,1,2,,855686,3213,Inactive,33946324.0,2770.0,,Potency,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore),Confirmatory,,
314,880,2,1,,855686,3213,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
315,880,2,1,,855686,3213,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
316,880,2,1,,11111147,3213,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
317,880,2,1,,11111147,3213,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
318,880,2,1,,50104008,3213,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
319,880,2,1,,50104008,3213,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
320,881,2,2,,855686,3213,Inactive,317373425.0,247.0,3.9811,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
321,881,2,2,,11111147,3213,Inactive,317373425.0,247.0,5.0119,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
322,883,1,3,,11111146,3213,Inconclusive,13699818.0,1559.0,39.8107,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
323,883,1,3,,11111147,3213,Inconclusive,13699818.0,1559.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
324,884,1,2,,855686,3213,Active,13435386.0,1576.0,0.3981,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
325,884,1,2,,11111147,3213,Active,13435386.0,1576.0,0.1585,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
326,885,1,2,,855686,3213,Inactive,13435386.0,1576.0,0.3981,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
327,885,1,2,,11111147,3213,Inactive,13435386.0,1576.0,0.1585,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
328,886,1,2,,855686,3213,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
329,886,1,2,,855686,3213,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
330,886,1,2,,11111146,3213,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
331,886,1,2,,11111146,3213,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
332,886,1,2,,11111147,3213,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
333,886,1,2,,11111147,3213,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
334,887,1,2,,855686,3213,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
335,887,1,2,,11111147,3213,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
336,889,1,3,,855686,3213,Inconclusive,1730092.0,840.0,12.5893,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
337,889,1,3,,11111147,3213,Inconclusive,1730092.0,840.0,12.5893,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
338,891,1,2,,11111146,3213,Active,40805836.0,1565.0,31.6228,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
339,891,1,2,,11111147,3213,Active,40805836.0,1565.0,6.3096,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
340,892,1,2,,855686,3213,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
341,892,1,2,,11111147,3213,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
342,893,1,2,,855686,3213,Inconclusive,122921310.0,,12.5893,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
343,893,1,2,,855686,3213,Inconclusive,122921311.0,,12.5893,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
344,893,1,2,,11111147,3213,Inconclusive,122921310.0,,12.5893,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
345,893,1,2,,11111147,3213,Inconclusive,122921311.0,,12.5893,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
346,894,2,1,,855686,3213,Inconclusive,31542939.0,3248.0,8.9125,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
347,894,2,1,,11111147,3213,Inconclusive,31542939.0,3248.0,5.0119,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
348,894,2,1,,50104008,3213,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
349,895,1,2,,855686,3213,Inconclusive,21620132.0,4790.0,1.4125,Potency,qHTS Assay for Identification of Small Molecule Antagonists for NFkB Signaling Pathway,Confirmatory,,
350,898,1,1,,855686,3213,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
351,899,1,2,,11111146,3213,Active,4503219.0,1557.0,6.3096,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
352,899,1,2,,11111147,3213,Active,4503219.0,1557.0,3.1623,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
353,900,1,3,,855686,3213,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
354,900,1,3,,11111147,3213,Inconclusive,15431328.0,834.0,12.5893,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
355,901,1,2,,855686,3213,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
356,901,1,2,,11111147,3213,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
357,902,1,2,,855686,3213,Active,120407068.0,7157.0,12.5893,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
358,902,1,2,,11111147,3213,Active,120407068.0,7157.0,10.0,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
359,912,1,2,,11111146,3213,Active,21392848.0,,10.0,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
360,912,1,2,,11111147,3213,Active,21392848.0,,5.0119,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
361,914,1,3,,855686,3213,Inconclusive,32879895.0,3091.0,5.0119,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
362,914,1,3,,11111146,3213,Inconclusive,32879895.0,3091.0,31.6228,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
363,914,1,3,,11111147,3213,Inconclusive,32879895.0,3091.0,12.5893,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
364,915,1,3,,855686,3213,Active,32879895.0,3091.0,5.0119,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
365,915,1,3,,11111146,3213,Inconclusive,32879895.0,3091.0,31.6228,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
366,915,1,3,,11111147,3213,Inconclusive,32879895.0,3091.0,12.5893,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
367,917,1,3,,855686,3213,Inconclusive,120660324.0,7066.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Agonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
368,918,1,3,,855686,3213,Active,120660324.0,7066.0,10.0,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Thrombopoietin (TPO) Signaling Pathway,Confirmatory,,
369,920,1,2,,855686,3213,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
370,922,1,2,,855686,3213,Inconclusive,15724400.0,6778.0,12.5893,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Antagonists of Stat Signaling Pathway,Confirmatory,,
371,922,1,2,,11111146,3213,Inconclusive,15724400.0,6778.0,7.9433,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Antagonists of Stat Signaling Pathway,Confirmatory,,
372,922,1,2,,11111147,3213,Inconclusive,15724400.0,6778.0,12.5893,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Antagonists of Stat Signaling Pathway,Confirmatory,,
373,923,1,2,,855686,3213,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
374,923,1,2,,11111147,3213,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
375,924,1,2,,855686,3213,Active,120407068.0,7157.0,12.5893,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
376,924,1,2,,11111147,3213,Inconclusive,120407068.0,7157.0,10.0,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
377,925,1,2,,11111146,3213,Active,4504349.0,3043.0,31.6228,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
378,925,1,2,,11111147,3213,Active,4504349.0,3043.0,12.5893,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
379,926,1,2,,11111146,3213,Inactive,38016895.0,7253.0,25.1189,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
380,926,1,2,,11111147,3213,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
381,927,1,3,,855686,3213,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
382,927,1,3,,11111147,3213,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
383,928,1,2,,855686,3213,Inconclusive,21620132.0,4790.0,1.4125,Potency,qHTS Assay for Identification of Small Molecule Agonists for NFkB Signaling Pathway,Confirmatory,,
384,932,1,4,,855686,3213,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
385,934,1,2,,855686,3213,Inconclusive,15724400.0,6778.0,100.0,Potency,Parental Cell Counter Screen for Stat Signaling Pathway Assay,Confirmatory,,
386,934,1,2,,11111146,3213,Active,15724400.0,6778.0,15.8489,Potency,Parental Cell Counter Screen for Stat Signaling Pathway Assay,Confirmatory,,
387,934,1,2,,11111147,3213,Inconclusive,15724400.0,6778.0,25.1189,Potency,Parental Cell Counter Screen for Stat Signaling Pathway Assay,Confirmatory,,
388,935,1,3,,855686,3213,Inconclusive,15724400.0,6778.0,12.5893,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Agonists of Stat Signaling Pathway,Confirmatory,,
389,935,1,3,,11111146,3213,Inconclusive,15724400.0,6778.0,7.9433,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Agonists of Stat Signaling Pathway,Confirmatory,,
390,935,1,3,,11111147,3213,Inconclusive,15724400.0,6778.0,12.5893,Potency,Confirmation Concentration-Response Assay for Identification of Small Molecule Agonists of Stat Signaling Pathway,Confirmatory,,
391,938,1,2,,11111146,3213,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
392,938,1,2,,11111147,3213,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
393,940,1,2,,855686,3213,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
394,940,1,2,,17405094,3213,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
395,943,1,2,,855686,3213,Inactive,18249941.0,25229.0,,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Kinetic Measurement of Intracellular Calcium Response,Confirmatory,,
396,944,1,2,,855686,3213,Active,18249941.0,25229.0,25.1189,Potency,qHTS Assay for Antagonists of Acetylcholine Muscarinic M1 Receptor: Measurement of IP-One Response,Confirmatory,,
397,945,1,4,,855686,3213,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
398,950,1,1,,855686,3213,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
399,951,1,1,,855686,3213,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
400,952,1,1,,855686,3213,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
401,954,1,2,,855686,3213,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle Pyruvate Kinase,Confirmatory,,
402,957,1,2,,855686,3213,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 4.5,Confirmatory,,
403,958,1,2,,855686,3213,Inactive,33286420.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle Pyruvate Kinase,Confirmatory,,
404,959,1,4,,855686,3213,Inactive,290753097.0,,,Potency,qHTS Validation Assay for Activators of Leishmania Mexicana Pyruvate Kinase,Confirmatory,,
405,992,1,3,,855686,3213,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Human alpha-Galactosidase at pH 4.5,Confirmatory,,
406,995,1,2,,855686,3213,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
407,995,1,2,,11111147,3213,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
408,997,1,2,,855686,3213,Inactive,52076901.0,4341833.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Rice alpha-Glucosidase at pH 5.0,Confirmatory,,
409,998,1,2,,855686,3213,Inactive,757912.0,2717.0,,Potency,Counterscreen for Glucocerebrosidase Inhibitors: qHTS Assay for Coffee Bean alpha-Galactosidase at pH 5.9,Confirmatory,,
410,1001,2,2,,855686,3213,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
411,1006,1,6,,855686,3213,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
412,1007,1,1,,855686,3213,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
413,1008,1,2,,855686,3213,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
414,1009,1,2,,855686,3213,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
415,1012,1,4,,855686,3213,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
416,1016,1,4,,855686,3213,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
417,1018,2,5,,855686,3213,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
418,1019,1,4,,855686,3213,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
419,1020,1,5,,855686,3213,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
420,1021,1,1,,855686,3213,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
421,1022,1,1,,855686,3213,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
422,1027,1,3,,855686,3213,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
423,1030,2,1,,855686,3213,Inconclusive,30582681.0,216.0,15.8489,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
424,1030,2,1,,11111147,3213,Inconclusive,30582681.0,216.0,7.0795,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
425,1030,2,1,,50104008,3213,Inconclusive,30582681.0,216.0,35.4813,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
426,1032,1,2,,855686,3213,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
427,1032,1,2,,855686,3213,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
428,1040,1,2,,855686,3213,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
429,1045,1,2,,855686,3213,Active,,,0.11699999999999999,EC50,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response,Confirmatory,,
430,1046,1,6,,855686,3213,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
431,1047,1,2,,855686,3213,Active,,,0.177,EC50,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response,Confirmatory,,
432,1048,1,1,,855686,3213,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
433,1048,1,1,,855686,3213,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
434,1049,1,1,,855686,3213,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
435,1049,1,1,,855686,3213,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
436,1050,1,2,,855686,3213,Inactive,6016094.0,8811.0,55.7,EC50,Dose Response cell-based high-throughput screening assay to identify agonists of galanin receptor 2 (GALR2),Confirmatory,,
437,1051,1,1,,855686,3213,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
438,1051,1,1,,855686,3213,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
439,1063,1,1,,855686,3213,Active,,,,,Leishmania major promastigote HTS,Screening,,
440,1085,1,1,,855686,3213,Active,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
441,1135,1,3,,855686,3213,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
442,1136,1,3,,855686,3213,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
443,1203,1,3,,855686,3213,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
444,1209,2,2,,855686,3213,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
445,1214,1,4,,855686,3213,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
446,1216,1,5,,855686,3213,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
447,1217,1,4,,855686,3213,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
448,1220,2,2,,855686,3213,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
449,1222,1,6,,855686,3213,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
450,1228,1,1,,855686,3213,Inactive,6016094.0,8811.0,55.7,EC50,Dose response counterscreen for agonists of galanin receptor 2 (GalR2): a cell-based high-throughput screening assay for activators of beta-lactamase activity,Confirmatory,,
451,1229,1,3,,855686,3213,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
452,1235,1,2,,855686,3213,Inactive,,,,,Alternative Pathway ELISA_orthogonal screening,Screening,,
453,1236,1,1,,855686,3213,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
454,1239,1,3,,855686,3213,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
455,1239,1,3,,855686,3213,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
456,1242,1,1,,855686,3213,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
457,1251,1,1,,855686,3213,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
458,1273,1,1,,855686,3213,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
459,1274,1,2,,855686,3213,Active,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
460,1276,1,1,,855686,3213,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
461,1285,1,1,,855686,3213,Active,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
462,1296,1,1,,855686,3213,Active,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
463,1304,1,2,,855686,3213,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
464,1321,1,2,,855686,3213,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
465,1325,1,2,,855686,3213,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
466,1326,1,4,,855686,3213,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
467,1332,1,1,,49698585,3213,Active,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
468,1359,1,4,,855686,3213,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
469,1362,1,2,,855686,3213,Active,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
470,1376,1,2,,855686,3213,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
471,1377,1,1,,855686,3213,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
472,1379,1,2,,855686,3213,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
473,1379,1,2,,11111147,3213,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
474,1379,1,2,,50104008,3213,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
475,1381,1,1,,855686,3213,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
476,1385,2,2,,855686,3213,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
477,1415,1,2,,855686,3213,Active,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
478,1415,1,2,,855686,3213,Active,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
479,1416,1,2,,855686,3213,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
480,1422,1,1,,855686,3213,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
481,1422,1,1,,17405094,3213,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
482,1423,1,2,,855686,3213,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
483,1423,1,2,,855686,3213,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
484,1424,1,1,,855686,3213,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
485,1430,1,1,,855686,3213,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
486,1434,2,3,,855686,3213,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
487,1434,2,3,,855686,3213,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
488,1439,1,1,,855686,3213,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
489,1439,1,1,,855686,3213,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
490,1440,1,1,,855686,3213,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
491,1440,1,1,,855686,3213,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
492,1441,1,1,,855686,3213,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
493,1441,1,1,,855686,3213,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
494,1443,1,3,,855686,3213,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
495,1445,1,1,,855686,3213,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
496,1446,1,3,,855686,3213,Active,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
497,1448,1,3,,855686,3213,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
498,1452,1,1,,855686,3213,Inconclusive,154426292.0,239.0,39.8107,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
499,1452,1,1,,11111147,3213,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
500,1454,1,1,,855686,3213,Inconclusive,66932916.0,5594.0,10.0,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
501,1454,1,1,,11111147,3213,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
502,1454,1,1,,50104008,3213,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
503,1456,1,1,,855686,3213,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
504,1457,1,1,,855686,3213,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
505,1457,1,1,,11111147,3213,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
506,1457,1,1,,50104008,3213,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
507,1458,1,1,,855686,3213,Inconclusive,10937869.0,6607.0,5.6234,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
508,1458,1,1,,11111147,3213,Inactive,10937869.0,6607.0,11.2202,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
509,1458,1,1,,50104008,3213,Inactive,10937869.0,6607.0,14.1254,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
510,1459,1,1,,50104008,3213,Inconclusive,27436948.0,4000.0,12.5893,Potency,Validation of Assay for Modulators of Lamin A Splicing,Confirmatory,,
511,1460,1,3,,855686,3213,Active,92096784.0,4137.0,11.2202,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
512,1460,1,3,,50104008,3213,Active,92096784.0,4137.0,10.0,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
513,1461,1,2,,855686,3213,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
514,1461,1,2,,50104008,3213,Inconclusive,46395496.0,387129.0,10.0,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
515,1463,1,1,,855686,3213,Inconclusive,,,12.5893,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
516,1463,1,1,,50104008,3213,Inconclusive,,,11.2202,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
517,1465,1,1,,855686,3213,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
518,1466,1,2,,855686,3213,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
519,1467,1,3,,855686,3213,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
520,1467,1,3,,11111147,3213,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
521,1467,1,3,,50104008,3213,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
522,1468,1,1,,855686,3213,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
523,1468,1,1,,50104008,3213,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
524,1469,1,1,,855686,3213,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
525,1469,1,1,,11111147,3213,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
526,1469,1,1,,50104008,3213,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
527,1471,2,1,,11111146,3213,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
528,1471,2,1,,11111147,3213,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
529,1476,2,1,,855686,3213,Inconclusive,281307097.0,,19.9526,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
530,1476,2,1,,11111147,3213,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
531,1476,2,1,,50104008,3213,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
532,1477,1,1,,855686,3213,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
533,1477,1,1,,11111147,3213,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
534,1477,1,1,,50104008,3213,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
535,1478,2,1,,855686,3213,Inconclusive,281307097.0,,25.1189,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
536,1478,2,1,,11111147,3213,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
537,1478,2,1,,50104008,3213,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
538,1479,1,2,,855686,3213,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
539,1479,1,2,,11111147,3213,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
540,1479,1,2,,50104008,3213,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
541,1481,1,2,,855686,3213,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
542,1486,1,3,,855686,3213,Active,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
543,1487,1,1,,855686,3213,Inconclusive,27436948.0,4000.0,11.2202,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
544,1487,1,1,,11111147,3213,Inconclusive,27436948.0,4000.0,7.9433,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
545,1487,1,1,,50104008,3213,Inconclusive,27436948.0,4000.0,10.0,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
546,1490,2,1,,855686,3213,Active,10954339.0,,22.3872,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
547,1490,2,1,,11111147,3213,Inconclusive,10954339.0,,14.1254,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
548,1496,1,4,,855686,3213,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
549,1496,1,4,,855686,3213,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
550,1504,1,4,,855686,3213,Active,34190601.0,2775.0,,,Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions.,Summary,,
551,1509,1,2,,855686,3213,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
552,1510,1,3,,855686,3213,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
553,1511,1,3,,855686,3213,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
554,1515,1,2,,855686,3213,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
555,1519,1,3,,11111147,3213,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
556,1519,1,3,,50104008,3213,Inconclusive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
557,1527,1,3,,855686,3213,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
558,1529,1,1,,855686,3213,Active,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
559,1530,1,1,,855686,3213,Active,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
560,1531,1,1,,855686,3213,Active,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
561,1532,1,1,,855686,3213,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
562,1554,1,1,,855686,3213,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
563,1556,1,4,,855686,3213,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
564,1565,2,2,,855686,3213,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
565,1566,2,3,,855686,3213,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
566,1578,3,2,,855686,3213,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
567,1619,1,2,,855686,3213,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
568,1621,1,2,,855686,3213,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
569,1626,1,2,,855686,3213,Active,,,0.465,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
570,1631,3,1,,855686,3213,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
571,1634,3,1,,855686,3213,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
572,1654,2,2,,855686,3213,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
573,1656,2,2,,855686,3213,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
574,1662,1,2,,855686,3213,Active,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
575,1663,1,2,,855686,3213,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
576,1665,2,2,,855686,3213,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
577,1672,1,3,,855686,3213,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
578,1688,1,1,,855686,3213,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
579,1700,1,2,,855686,3213,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
580,1705,1,2,,50104008,3213,Active,6980812.0,,3.1623,Potency,qHTS Validation Assay for Inhibitors of the Human Apurinic/apyrimidinic  Endonuclease 1 (APE1),Confirmatory,,
581,1706,1,2,,855686,3213,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
582,1707,1,3,,50104008,3213,Inactive,,,,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Validation Assay,Confirmatory,,
583,1708,1,3,,50104008,3213,Active,405898.0,,2.8184,Potency,Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV,Confirmatory,,
584,1721,1,2,,855686,3213,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
585,1722,1,2,,855686,3213,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
586,1766,1,1,,855686,3213,Inconclusive,18860839.0,4221.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
587,1766,1,1,,855686,3213,Inconclusive,56550039.0,4297.0,28.1838,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
588,1766,1,1,,11111147,3213,Inconclusive,18860839.0,4221.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
589,1766,1,1,,11111147,3213,Inconclusive,56550039.0,4297.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
590,1766,1,1,,50104008,3213,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
591,1766,1,1,,50104008,3213,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
592,1768,1,1,,855686,3213,Inconclusive,18860839.0,4221.0,15.8489,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
593,1768,1,1,,855686,3213,Inconclusive,56550039.0,4297.0,15.8489,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
594,1768,1,1,,11111147,3213,Inconclusive,18860839.0,4221.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
595,1768,1,1,,11111147,3213,Inconclusive,56550039.0,4297.0,19.9526,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
596,1768,1,1,,50104008,3213,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
597,1768,1,1,,50104008,3213,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
598,1775,1,2,,855686,3213,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
599,1776,1,2,,855686,3213,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
600,1777,3,2,,855686,3213,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
601,1778,3,3,,855686,3213,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
602,1779,2,2,,855686,3213,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
603,1783,1,1,,855686,3213,Inactive,,,,,Counter screen for biotinylated proteins binding to avidin beads,Screening,,
604,1789,1,2,,855686,3213,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
605,1800,1,2,,855686,3213,Active,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
606,1813,1,2,,855686,3213,Active,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
607,1814,1,2,,855686,3213,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
608,1815,1,1,,50104008,3213,Active,,,0.7943,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 7G8,Confirmatory,,
609,1816,1,1,,50104008,3213,Active,,,0.3981,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4,Confirmatory,,
610,1817,2,2,,855686,3213,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
611,1822,1,3,,855686,3213,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
612,1825,1,1,,855686,3213,Active,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
613,1828,2,1,,50104008,3213,Active,,,,,qHTS for Inhibitors of Plasmodium falciparum proliferation: Summary,Summary,,
614,1832,2,1,,855686,3213,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
615,1836,1,1,,855686,3213,Inactive,10567816.0,2775.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
616,1836,1,1,,855686,3213,Inactive,74355113.0,85397.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
617,1837,1,1,,855686,3213,Inactive,1166512.0,6000.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
618,1837,1,1,,855686,3213,Inactive,10567816.0,2775.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
619,1838,1,1,,855686,3213,Inactive,10567816.0,2775.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
620,1838,1,1,,855686,3213,Inactive,156416009.0,6004.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
621,1840,1,1,,855686,3213,Inactive,10567816.0,2775.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
622,1840,1,1,,855686,3213,Inactive,86301151.0,5999.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
623,1841,1,1,,855686,3213,Inactive,10567816.0,2775.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
624,1841,1,1,,855686,3213,Inactive,86990435.0,10287.0,,,"Single point concentration, multiplexed high-throughput screen for confirmation of small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
625,1845,1,2,,855686,3213,Active,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
626,1850,2,1,,855686,3213,Active,,,18.79,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
627,1851,1,2,,11111147,3213,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
628,1851,1,2,1.0,11111147,3213,Active,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
629,1851,1,2,2.0,11111147,3213,Active,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
630,1851,1,2,3.0,11111147,3213,Active,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
631,1851,1,2,4.0,11111147,3213,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
632,1851,1,2,5.0,11111147,3213,Inconclusive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
633,1861,2,1,,855686,3213,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
634,1862,1,4,,855686,3213,Inconclusive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_RPL19A,Screening,,
635,1863,2,1,,855686,3213,Active,,,26.27,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
636,1865,1,1,,855686,3213,Inconclusive,,,3.9811,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
637,1865,1,1,,11111147,3213,Inconclusive,,,8.9125,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
638,1865,1,1,,50104008,3213,Inconclusive,,,17.7828,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
639,1867,1,4,,855686,3213,Inconclusive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_MEP2,Screening,,
640,1868,1,4,,855686,3213,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
641,1870,1,4,,855686,3213,Unspecified,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_CIT2,Screening,,
642,1873,1,4,,855686,3213,Inconclusive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_LAP4,Screening,,
643,1875,2,1,,855686,3213,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
644,1876,1,1,,50104008,3213,Active,,,0.4467,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7,Confirmatory,,
645,1877,1,1,,50104008,3213,Active,,,1.9953,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line D10,Confirmatory,,
646,1882,1,1,,50104008,3213,Active,,,1.122,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line Dd2,Confirmatory,,
647,1883,1,1,,50104008,3213,Active,,,0.7079,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2,Confirmatory,,
648,1885,2,1,,855686,3213,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
649,1886,1,1,,50104008,3213,Active,,,1.4125,Potency,qHTS for differential inhibitors of proliferation of Plasmodium falciparum line HB3,Confirmatory,,
650,1887,1,4,,855686,3213,Unspecified,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_AGP1,Screening,,
651,1892,1,1,,855686,3213,Inactive,22035600.0,5871.0,,,"Single Concentration Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
652,1893,1,1,,855686,3213,Inactive,22035600.0,5871.0,,,"Single Concentration Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
653,1894,1,1,,855686,3213,Inactive,42794767.0,4215.0,,,"Single Concentration Confirmation Screen via Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
654,1899,1,3,,855686,3213,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
655,1900,1,1,,855686,3213,Active,,,2.251,EC50,Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus,Confirmatory,,
656,1902,1,1,,855686,3213,Active,15675770.0,901648.0,3.0239999999999996,EC50,Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity,Confirmatory,,
657,1903,2,3,,855686,3213,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
658,1906,1,3,,855686,3213,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
659,1907,1,2,,855686,3213,Active,,,,,Luminescence-based confirmation cell-based assay for cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
660,1910,1,2,,855686,3213,Inconclusive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
661,1914,1,2,,855686,3213,Inactive,15675770.0,901648.0,150.0,EC50,Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression,Confirmatory,,
662,1915,1,2,,855686,3213,Active,,,7.702000000000001,EC50,Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus,Confirmatory,,
663,1943,1,2,,855686,3213,Active,125541954.0,,,,Fluorescence-based confirmation biochemical high throughput screening assay for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
664,1945,1,2,,855686,3213,Active,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID) in triplicate.,Screening,,
665,1947,1,2,,855686,3213,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
666,1948,1,1,,11111147,3213,Inactive,,,7.9433,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
667,1948,1,1,,50104008,3213,Inactive,,,7.9433,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
668,1950,1,3,,855686,3213,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
669,1956,1,1,,855686,3213,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
670,1961,2,2,,855686,3213,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
671,1962,1,2,,855686,3213,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
672,1967,1,1,,85231031,3213,Inconclusive,4505907.0,5376.0,7.5686,Potency,qHTS Assay for Modulators of Human Peripheral Myelin Protein 22 (PMP22) Expression/Activity,Confirmatory,,
673,1974,1,2,,855686,3213,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
674,1981,2,1,,855686,3213,Active,,,69.74,IC50,A screen for inhibitors of the PhoP regulon in Salmonella Typhimurium using a modified counterscreen.,Confirmatory,,
675,1984,1,3,,855686,3213,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
676,1985,2,1,,855686,3213,Active,,,32.891,IC50,A screen for inhibitors of the PhoP regulon in Salmonella Typhi using a modified counterscreen,Confirmatory,,
677,1986,1,2,,855686,3213,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
678,1987,1,2,,855686,3213,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
679,1988,1,2,,855686,3213,Inconclusive,,,,EC50,Luminescence Cell-Based Dose Confimation HTS to Identify Inhibitors of of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells,Confirmatory,,
680,1990,1,2,,855686,3213,Inconclusive,,,,EC50,Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells,Confirmatory,,
681,1994,1,2,,855686,3213,Inactive,,,120.0,EC50,Luminescence Cell-Based Dose Response HTS to Identify Inhibitors of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells,Confirmatory,,
682,2006,3,2,,855686,3213,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
683,2006,3,2,,855686,3213,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
684,2006,3,2,,855686,3213,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
685,2012,3,2,,855686,3213,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
686,2013,2,2,,855686,3213,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
687,2014,3,2,,855686,3213,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
688,2016,1,3,,855686,3213,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
689,2023,1,3,,855686,3213,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
690,2025,1,3,,855686,3213,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
691,2029,1,3,,855686,3213,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
692,2052,2,1,,855686,3213,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
693,2057,1,2,,855686,3213,Active,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
694,2058,3,2,,855686,3213,Active,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
695,2066,1,4,,855686,3213,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
696,2071,2,2,,855686,3213,Active,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
697,2073,2,3,,855686,3213,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
698,2073,2,3,,855686,3213,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
699,2094,1,2,,855686,3213,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
700,2094,1,2,,855686,3213,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
701,2094,1,2,,855686,3213,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
702,2097,1,2,,855686,3213,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
703,2098,1,1,,855686,3213,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
704,2099,1,1,,855686,3213,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
705,2100,1,1,,855686,3213,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
706,2101,1,1,,855686,3213,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
707,2101,1,1,,11111147,3213,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
708,2101,1,1,,50104008,3213,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
709,2107,1,1,,855686,3213,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
710,2107,1,1,,11111147,3213,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
711,2107,1,1,,50104008,3213,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
712,2110,1,1,,50104008,3213,Active,119393891.0,2548.0,35.4813,Potency,Confirmation of Inhibitors and Activators of Purified Human alpha-Glucosidase Using an Alternate Red Fluorescent Susbtrate,Confirmatory,,
713,2112,1,1,,855686,3213,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
714,2112,1,1,,11111147,3213,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
715,2112,1,1,,50104008,3213,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
716,2129,1,2,,855686,3213,Active,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
717,2130,1,3,,855686,3213,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
718,2147,1,1,,855686,3213,Active,221046486.0,,12.5893,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
719,2147,1,1,,11111147,3213,Inconclusive,221046486.0,,11.2202,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
720,2147,1,1,,50104008,3213,Inconclusive,221046486.0,,17.7828,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
721,2156,2,2,,855686,3213,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
722,2174,1,3,,855686,3213,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
723,2177,1,3,,855686,3213,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
724,2205,1,1,,855686,3213,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
725,2216,1,3,,855686,3213,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
726,2221,1,2,,855686,3213,Inconclusive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
727,2227,1,2,,855686,3213,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
728,2234,1,2,,855686,3213,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
729,2235,1,2,,855686,3213,Active,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
730,2237,1,2,,855686,3213,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
731,2239,1,2,,855686,3213,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
732,2240,1,1,,85787856,3213,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
733,2241,1,1,,85787856,3213,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
734,2242,1,1,,855686,3213,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
735,2247,1,2,,855686,3213,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
736,2252,1,1,,855686,3213,Active,,,2.72,EC50,A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen,Confirmatory,,
737,2253,1,1,,855686,3213,Active,,,2.53,EC50,A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhimurium identified in the primary screen,Confirmatory,,
738,2275,1,1,,85787856,3213,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
739,2280,2,3,,855686,3213,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
740,2288,1,1,,855686,3213,Inconclusive,,,6.5614,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
741,2289,1,1,,855686,3213,Inconclusive,,,6.5614,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
742,2297,1,2,,85860003,3213,Unspecified,,,,,Inhibition Frequency Index,Other,,
743,2300,1,3,,855686,3213,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
744,2302,1,2,,85860003,3213,Active,111034851.0,,,,Inhibition of P. falciparum Dd2,Screening,,
745,2303,1,2,,85860003,3213,Inactive,,,,,Inhibition of HepG2 cell line,Screening,,
746,2304,1,2,,85860003,3213,Inactive,111034851.0,,,,Inhibition of P. falciparum LDH,Screening,,
747,2305,1,2,,85860003,3213,Unspecified,,,0.8,XC50_3D7,XC50 for P. falciparum 3D7,Confirmatory,,
748,2306,1,2,,85860003,3213,Active,124513266.0,814112.0,,,Inhibition of P. falciparum 3D7,Screening,,
749,2313,1,1,,85787856,3213,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
750,2314,1,2,,855686,3213,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
751,2314,1,2,,855686,3213,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
752,2315,1,2,,855686,3213,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
753,2315,1,2,,855686,3213,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
754,2316,1,1,,85787856,3213,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
755,2322,1,1,,85787856,3213,Active,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
756,2323,1,1,,50104008,3213,Inactive,254220970.0,,35.4813,Potency,qHTS Validation Assay for Identification of Novel General Anesthetics,Confirmatory,,
757,2326,1,1,,855686,3213,Inactive,194352380.0,,2.5119,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
758,2326,1,1,,50104008,3213,Inactive,194352380.0,,7.9433,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
759,2330,1,1,,85787856,3213,Active,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
760,2353,1,3,,50104008,3213,Active,282403581.0,,10.0,Potency,qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
761,2364,1,2,,50104008,3213,Inactive,4557365.0,641.0,7.9433,Potency,qHTS Validation Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
762,2380,1,2,,855686,3213,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
763,2384,1,1,,855686,3213,Active,,,21.19,IC50,A counter screen for small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
764,2391,1,1,,855686,3213,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
765,2401,1,2,,855686,3213,Active,,,19.56,IC50,A Counter Screen to identiry small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
766,2417,1,1,,855686,3213,Active,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
767,2435,1,2,,855686,3213,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
768,2441,1,1,,50104008,3213,Inconclusive,,,28.1838,Potency,Cell cycle validation with wells to cells screening paradigm,Confirmatory,,
769,2445,1,2,,855686,3213,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
770,2451,1,2,,855686,3213,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
771,2451,1,2,,11111147,3213,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
772,2451,1,2,,50104008,3213,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
773,2462,1,1,,855686,3213,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
774,2462,1,1,,855686,3213,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
775,2472,1,2,,855686,3213,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
776,2472,1,2,,11111147,3213,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
777,2517,2,1,,855686,3213,Inconclusive,6980812.0,,5.0119,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
778,2517,2,1,,11111147,3213,Inconclusive,6980812.0,,3.1623,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
779,2517,2,1,,50104008,3213,Inconclusive,6980812.0,,4.4668,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
780,2520,1,4,,855686,3213,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
781,2521,1,3,,855686,3213,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
782,2523,1,1,,855686,3213,Inactive,124486680.0,16408.0,,,HTS of MLPCN Validation Compound Set for developing T Cell Immune Modulators,Screening,,
783,2524,1,2,,855686,3213,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
784,2528,1,2,,855686,3213,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
785,2528,1,2,,11111147,3213,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
786,2528,1,2,,50104008,3213,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
787,2540,1,2,,855686,3213,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
788,2544,1,2,,855686,3213,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
789,2546,1,1,,855686,3213,Active,188536040.0,19885.0,5.6234,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
790,2546,1,1,,11111147,3213,Active,188536040.0,19885.0,7.0795,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
791,2549,1,1,,855686,3213,Active,282403581.0,,4.4668,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
792,2549,1,1,,11111147,3213,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
793,2549,1,1,,50104008,3213,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
794,2550,1,3,,855686,3213,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
795,2551,1,1,,855686,3213,Active,188536040.0,19885.0,10.0,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
796,2551,1,1,,11111147,3213,Active,188536040.0,19885.0,10.0,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
797,2553,1,2,,855686,3213,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
798,2557,1,3,,855686,3213,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
799,2563,1,1,,855686,3213,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
800,2565,1,1,,50104008,3213,Active,405898.0,,1.0,Potency,Counterscreen for APE1 Inhibitors: qHTS Assay for Inhibitors of Endonuclease IV,Confirmatory,,
801,2572,1,1,,50104008,3213,Inconclusive,6980812.0,,7.9433,Potency,Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
802,2599,1,2,,855686,3213,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
803,2606,1,2,,855686,3213,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
804,2629,1,1,,855686,3213,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
805,2629,1,1,,56424143,3213,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
806,2642,1,2,,855686,3213,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
807,2648,1,2,,855686,3213,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
808,2650,2,1,,855686,3213,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
809,2660,1,1,,90341166,3213,Inconclusive,4826730.0,2475.0,26.1216,Potency,"Cytometric Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
810,2661,1,1,,855686,3213,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
811,2662,2,1,,855686,3213,Inconclusive,56550039.0,4297.0,10.0,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
812,2662,2,1,,85231031,3213,Inconclusive,56550039.0,4297.0,1.5849,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
813,2666,1,1,,90341166,3213,Inconclusive,4826730.0,2475.0,26.1216,Potency,"High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells",Confirmatory,,
814,2667,1,1,,90341166,3213,Inactive,4826730.0,2475.0,,Potency,High Content Imaging Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF Cells,Confirmatory,,
815,2668,1,1,,90341166,3213,Inconclusive,4826730.0,2475.0,13.0918,Potency,Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells,Confirmatory,,
816,2674,1,1,,855686,3213,Inactive,34810098.0,,,,HTS for Identification of VLA-4 Allosteric Modulators from Validation Compound Set.,Screening,,
817,2675,1,1,,855686,3213,Inconclusive,41281591.0,4154.0,17.7828,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
818,2675,1,1,,50104008,3213,Unspecified,41281591.0,4154.0,,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
819,2676,1,2,,855686,3213,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
820,2685,1,1,,855686,3213,Inconclusive,,,11.5821,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
821,2690,1,2,,855686,3213,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
822,2706,1,1,,855686,3213,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide for Validation Compound Set,Screening,,
823,2708,1,1,,11111147,3213,Inconclusive,282403581.0,,31.6228,Potency,Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
824,2716,1,1,,855686,3213,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
825,2716,1,1,,56424143,3213,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
826,2717,1,2,,855686,3213,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
827,2718,1,1,,855686,3213,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
828,2729,1,1,,855686,3213,Inactive,,,,Potency,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment: WI-38 Cytotoxicity,Confirmatory,,
829,2730,1,1,,855686,3213,Inconclusive,4506243.0,5725.0,12.5893,Potency,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment: Confirmation of PNC Inhibition,Confirmatory,,
830,2731,1,1,,855686,3213,Inactive,4506243.0,5725.0,,Potency,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment: PC3M Caspase 3/7 Activation,Confirmatory,,
831,2732,1,1,,855686,3213,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
832,2732,1,1,,17405094,3213,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
833,2733,1,1,,855686,3213,Active,4506243.0,5725.0,31.6228,Potency,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment: PC3M Cytotoxicity,Confirmatory,,
834,2734,1,1,,855686,3213,Inactive,4506243.0,5725.0,,Potency,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment: DNA Intercalation/PicoGreen Displacement Assay,Confirmatory,,
835,2751,2,2,,855686,3213,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
836,2774,1,3,,92304042,3213,Inactive,,,,,LOPAC Circadian Assay,Screening,,
837,2796,1,4,,855686,3213,Active,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
838,2797,1,2,,855686,3213,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
839,2805,2,2,,855686,3213,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
840,2806,2,2,,855686,3213,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
841,2825,1,2,,855686,3213,Active,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
842,8289,6,2,,103184924,3213,Active,,,10.0,IC50,In vitro cytotoxic activity against human lung A549 cell line ( standard deviation in parenthesis),Confirmatory,12036369.0,
843,8480,6,2,,103184924,3213,Active,,,1.22,IC50,In vitro cytotoxicity against human A549 (lung cancer) cell line.,Confirmatory,15177438.0,
844,9272,6,2,,103184924,3213,Active,,,0.41,GI50,Tested in vitro for cytotoxicity in A549/ATCC cell lines,Confirmatory,8035426.0,
845,25321,3,4,,103184924,3213,Unspecified,,,,,Acid ionization constant is determined,Other,7932579.0,
846,26756,3,4,,103184924,3213,Unspecified,,,,,DNA binding dissociation constant as KD,Other,6708048.0,
847,41223,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against BC-1 cell line,Other,12657257.0,
848,42713,6,2,,103184924,3213,Active,,,1.01,GI50,Tested in vitro for cytotoxicity in CAKI-1 cell lines,Confirmatory,8035426.0,
849,43548,6,2,,103184924,3213,Active,,,0.415,GI50,Tested in vitro for cytotoxicity in CCRF-CEM cell lines,Confirmatory,8035426.0,
850,43612,6,2,,103184924,3213,Unspecified,,,,,Cytotoxic concentration of compound against human breast cancer cells,Other,12729658.0,
851,46285,6,2,,103184924,3213,Active,,,0.588,GI50,Tested in vitro for cytotoxicity in COLO 205 cell lines,Confirmatory,8035426.0,
852,52335,6,2,,103184924,3213,Active,,,1.22,IC50,In vitro cytotoxicity against human Col2 (colon cancer) cell line.,Confirmatory,15177438.0,
853,54077,6,2,,103184924,3213,Active,,,0.552,GI50,Tested in vitro for cytotoxicity in DMS114 cell lines,Confirmatory,8035426.0,
854,54438,6,2,,103184924,3213,Active,,,22.2,EC50,In vitro inhibition of calf thymus DNA/ethidium bromide complex formation.,Confirmatory,12036369.0,
855,54631,3,3,,103184924,3213,Unspecified,,,,,Binding rate constant for DNA binding,Other,4009597.0,
856,54999,6,1,,103184924,3213,Unspecified,,,,,Increase of calf thymus DNA denaturation temperature (delta Tm),Other,7932579.0,
857,55143,3,3,,103184924,3213,Unspecified,,,,,Inhibitory concentration against ethidium bromide binding to DNA,Other,4009597.0,
858,55296,3,3,,103184924,3213,Active,,,,,Concentration at which the fluorescence of an ethidium-DNA complex was reduced by 50%,Other,3806584.0,
859,78564,6,2,,103184924,3213,Active,,,1.8,IC50,Compound was evaluated for inhibitory activity against H69 human lung cancer cell line,Confirmatory,1479585.0,
860,78720,6,2,,103184924,3213,Active,,,0.2,IC50,Compound was evaluated for inhibitory activity against H 358 human lung cancer cell line,Confirmatory,1479585.0,
861,78722,6,2,,103184924,3213,Active,,,0.51,IC50,Compound was evaluated for inhibitory activity against H 460 human lung cancer cell line,Confirmatory,1479585.0,
862,80529,6,2,,103184924,3213,Active,,,0.29,GI50,Cytotoxic effect on growth inhibition of colon cancer HCT116 cells,Confirmatory,8765520.0,
863,81866,8,1,,103184924,3213,Active,,,0.26,ID50,Inhibitory effect against HCT8 Human colon adenocarcinoma,Confirmatory,3806584.0,
864,85757,6,2,,103184924,3213,Active,,,15.0,IC50,In vitro cytotoxic activity against human colon HT-29 cell line ( standard deviation in parenthesis),Confirmatory,12036369.0,
865,87000,3,6,,103184924,3213,Unspecified,,,,,Effect on [3H]-Thymidine incorporation by HeLa cells measured as percent incorporation compared to control 3 hr after washing at a concentration of 10 ug/mL,Other,3599025.0,
866,87001,3,6,,103184924,3213,Unspecified,,,,,Effect on [3H]-Thymidine incorporation by HeLa cells measured as percent incorporation compared to control 3 hr after washing at a concentration of 25 ug/mL,Other,3599025.0,
867,87003,3,6,,103184924,3213,Unspecified,,,,,Effect on [3H]thymidine incorporation by HeLa cells measured as percent incorporation compared to control 3 h after washing at a concentration of 5 ug/mL,Other,3599025.0,
868,87005,3,5,,103184924,3213,Unspecified,,,,,Effect on [3H]-Thymidine incorporation by HeLa cells measured as percent incorporation compared to control in the presence of drug at a concentration of 10 ug/mL,Other,3599025.0,
869,87006,3,6,,103184924,3213,Unspecified,,,,,Effect on [3H]thymidine incorporation by HeLa cells measured as percent incorporation compared to control in the presence of drug at a concentration of 25 ug/mL,Other,3599025.0,
870,87008,3,5,,103184924,3213,Unspecified,,,,,Effect on [3H]-Thymidine incorporation by HeLa cells measured as percent incorporation compared to control in the presence of drug at a concentration of 5 ug/mL,Other,3599025.0,
871,90125,7,2,,103184924,3213,Active,,,2.9,TGI,Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in brain tumor sub panel,Confirmatory,8035425.0,
872,90126,7,2,,103184924,3213,Active,,,3.0,TGI,Concentration yielding an amount of cellular protein at the end of the incubation that is the same as at the beginning of the incubation in full panel,Confirmatory,8035425.0,
873,93491,6,2,,103184924,3213,Active,,,0.862,GI50,Tested in vitro for cytotoxicity in IGROV1 cell lines,Confirmatory,8035426.0,
874,93502,6,2,,103184924,3213,Active,,,0.86,GI50,Cytotoxic effect on growth inhibition of ovarian cancer IGROVI cells,Confirmatory,8765520.0,
875,95832,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against KB cell line,Other,12657257.0,
876,96015,8,1,,103184924,3213,Unspecified,,,,,Cytotoxicity in vitro against KB cell line,Other,7932579.0,
877,96352,6,2,,103184924,3213,Unspecified,,,,,Cytotoxic concentration of compound against human epidermal carcinoma (KB) cell line,Other,12729658.0,
878,96644,8,1,,103184924,3213,Active,,,0.99,ID50,"Compound was tested for its antitumor activity against murine leukemia L1210 cells in vitro, expressed as ID50",Confirmatory,7265115.0,
879,96665,8,1,,103184924,3213,Active,,,0.99,ID50,Growth inhibitory activity against L1210 lymphocytic leukemia cells.,Confirmatory,6413693.0,
880,97840,7,1,,103184924,3213,Active,,,,,Lethal concentration required to reduce cloning efficiency of L1210 cell line to a factor of 0.37 after 24 hour exposure,Other,4009597.0,
881,97904,4,4,,103184924,3213,Unspecified,,,,,"Compound was tested for its cytotoxic activity against murine leukemia L1210 cells in mice after intraperitoneal treatment, expressed as LD0 (highest nonlethal dose).",Other,7265115.0,
882,98049,8,1,,103184924,3213,Active,,,0.85,ED50,The effective dose against L1210 cell growth,Confirmatory,4009597.0,
883,99087,6,3,,103184924,3213,Active,,,0.5,IC50,The compound was tested in vitro for growth inhibitory activity against murine leukemia L1210 cells,Confirmatory,,
884,100465,8,1,,103184924,3213,Active,,,0.1,ID50,Inhibitory effect against L1210 leukemia in tissue culture,Confirmatory,3806584.0,
885,100689,6,2,,103184924,3213,Active,,,0.56,GI50,Cytotoxic effect on growth inhibition of melanoma LOX IMVI cells,Confirmatory,8765520.0,
886,101087,8,1,,103184924,3213,Active,,,0.99,ID50,Antitumor activity against L1210 leukemia cells expressed as dose concentration that reduces number of cells by 50% after 48 hrs exposure to drug.,Confirmatory,4009591.0,
887,101787,6,2,,103184924,3213,Active,,,2.3,IC50,In vitro cytotoxic activity against human breast MDA-MB-231 cell line ( standard deviation in parenthesis),Confirmatory,12036369.0,
888,102404,6,2,,103184924,3213,Active,,,2.52,GI50,Tested in vitro for cytotoxicity in MALME-3M,Confirmatory,8035426.0,
889,103737,6,2,,103184924,3213,Active,,,0.71,GI50,Cytotoxic effect on growth inhibition of breast cancer MCF-7 cells,Confirmatory,8765520.0,
890,103738,6,2,,103184924,3213,Active,,,0.74,GI50,Cytotoxic effect of growth inhibition of breast cancer MCF-7/ADR-RES cells,Confirmatory,8765520.0,
891,105274,6,2,,103184924,3213,Active,,,0.38,GI50,Cytotoxic effect on leukemia MOLT-4 cells,Confirmatory,8765520.0,
892,116287,3,3,,103184924,3213,Unspecified,,,,,Increase in life span over controls (10e5 cells) in mice after intraperitoneal treatment of the compound.,Other,7265115.0,
893,116694,3,4,,103184924,3213,Unspecified,,,,,Cytotoxicity against L1210 leukemia cells administered through intraperitoneal route in mice,Other,4009591.0,
894,117502,3,3,,103184924,3213,Unspecified,,,,,The effect on oxygen consumed in the presence of MPO-H2O2.,Other,7265115.0,
895,117798,3,3,,103184924,3213,Unspecified,,,,,The effect on NADH oxidation in the presence of MPO-H2O2.,Other,7265115.0,
896,130790,3,3,,103184924,3213,Unspecified,,,,,Antitumor activity against ip implanted L1210 leukemia in mouse after ip administration of 120 mg/kg for 5 days expressed as increase in mean life span,Other,3385725.0,
897,130808,3,4,,103184924,3213,Unspecified,,,,,Antitumor activity against ip implanted syngeneic P388 leukemia in mouse after ip administration of 60 mg/kg for 5 days expressed as increase in mean life span,Other,3385725.0,
898,130810,5,2,,103184924,3213,Inconclusive,,,,,Antitumor activity against iv implanted L1210 leukemia in mouse after ip administration for 5 days expressed as increase in mean life span; NT=Not tested,Other,3385725.0,
899,130974,5,2,,103184924,3213,Inconclusive,,,,,Antitumor activity against iv implanted syngeneic P388 leukemia in mouse after ip administration for 5 days expressed as increase in mean life span; NT=Not tested,Other,3385725.0,
900,131305,5,2,,103184924,3213,Inconclusive,,,,,Effect on ip implanted syngeneic B16 melanoma by ip administration for 5 days measured as increase in mean life span; NT=Not tested,Other,3385725.0,
901,132178,5,2,,103184924,3213,Inconclusive,,,,,"Inhibition of sc implanted syngeneic colon 38 carcinoma by ip administration on 1, 3, 5, 7, 9 days measured as inhibition ratio; NT=Not tested",Other,3385725.0,
902,143741,6,2,,103184924,3213,Active,,,0.87,IC50,Compound was evaluated for inhibitory activity against N 417 human lung cancer cell line,Confirmatory,1479585.0,
903,145089,6,2,,103184924,3213,Active,,,0.31,GI50,Cytotoxic effect on growth inhibition of nonsmall cell lung cancer NCI-H322M cells,Confirmatory,8765520.0,
904,153786,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as percent increase in lifespan (% ILS) relative to controls after intraperitoneal administration of 10 mg/kg,Other,3599025.0,
905,153788,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as percent increase in lifespan (% ILS) relative to controls after intraperitoneal administration of 20 mg/kg,Other,3599025.0,
906,153789,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as percent increase in lifespan (% ILS) relative to controls after intraperitoneal administration of 40 mg/kg,Other,3599025.0,
907,153790,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as percent increase in lifespan (% ILS) relative to controls after intraperitoneal administration of 5 mg/kg,Other,3599025.0,
908,153945,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as median survival time (MST) after intraperitoneal administration of 10 mg/kg,Other,3599025.0,
909,153947,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as median survival time (MST) after intraperitoneal administration of 20 mg/kg,Other,3599025.0,
910,153948,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as median survival time (MST) after intraperitoneal administration of 40 mg/kg,Other,3599025.0,
911,153949,3,4,,103184924,3213,Unspecified,,,,,Activity against P388 lymphocytic leukemia in BDFR-1 mice measured as median survival time (MST) after intraperitoneal administration of 5 mg/kg,Other,3599025.0,
912,200456,6,2,,103184924,3213,Active,,,0.73,GI50,Cytotoxic effect on growth inhibition of renal cancer SN12C cells,Confirmatory,8765520.0,
913,200816,6,2,,103184924,3213,Unspecified,,,,,Cytotoxic concentration of compound against human small cell lung cancer (NCI-187),Other,12729658.0,
914,200831,6,2,,103184924,3213,Active,,,2.0,IC50,In vitro cytotoxicity against human SNU-638 (stomach cancer) cell line.,Confirmatory,15177438.0,
915,200935,6,2,,103184924,3213,Active,,,0.816,GI50,Tested in vitro for cytotoxicity in SF-268 cell lines,Confirmatory,8035426.0,
916,213727,6,2,,103184924,3213,Active,,,0.93,GI50,Cytotoxic effect on growth inhibition of CNS cancer U251 cells,Confirmatory,8765520.0,
917,223608,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey kidney fibroblast (vero cell),Other,12773043.0,
918,231710,3,4,,103184924,3213,Unspecified,,,,,Ratio between brain tumor full panel [A] and sub panel [B],Other,8035425.0,
919,235001,3,5,,103184924,3213,Unspecified,,,,,TGI correlation coefficient value of the compound,Other,8035425.0,
920,255004,9,5,,103184924,3213,Unspecified,125472.0,3815.0,10.0,IC50,Inhibitory concentration against c-Kit wild type expressed in recombinant baculovirus,Confirmatory,16190746.0,
921,255976,7,6,,103184924,3213,Active,125472.0,3815.0,0.2,IC50,Inhibitory concentration against IL-3 independent Ba/F3 Kit D816V cell line,Confirmatory,16190746.0,
922,255987,7,6,,103184924,3213,Active,125472.0,3815.0,0.2,IC50,Inhibitory concentration against IL-3 independent Ba/F3 Kit cell line with SCF (kit-ligand),Confirmatory,16190746.0,
923,256551,9,5,,103184924,3213,Unspecified,125472.0,3815.0,10.0,IC50,Inhibitory concentration against c-Kit D816V type expressed in recombinant baculovirus,Confirmatory,16190746.0,
924,275527,6,2,,103184924,3213,Active,,,0.19,IC50,Cytotoxicity against mouse L1210 cell line,Confirmatory,17228871.0,
925,275528,6,2,,103184924,3213,Active,,,14.9,IC50,Cytotoxicity against human HT29 cell line,Confirmatory,17228871.0,
926,275533,3,4,,103184924,3213,Unspecified,,,,,Cell cycle arrest in mouse L1210 cell line by accumulation at G2 phase at 1 uM after 24 hrs,Other,17228871.0,
927,276023,6,2,,103184924,3213,Active,,,2.4,IC50,Cytotoxicity against human KB cells,Confirmatory,16919455.0,
928,276024,6,3,,103184924,3213,Active,,,2.7,IC50,Cytotoxicity against human BC cells,Confirmatory,16919455.0,
929,276025,6,2,,103184924,3213,Active,,,1.9,IC50,Cytotoxicity against human NCI-H187 cells,Confirmatory,16919455.0,
930,283892,6,2,,103184924,3213,Active,,,2.07,IC50,Cytotoxicity against human A549 cells after 3 days by SRB assay,Confirmatory,17035025.0,
931,283893,6,3,,103184924,3213,Active,,,5.97,IC50,Cytotoxicity against human SNU638 cells after 3 days by SRB assay,Confirmatory,17035025.0,
932,283894,6,2,,103184924,3213,Active,,,1.82,IC50,Cytotoxicity against human Col2 cells after 3 days by SRB assay,Confirmatory,17035025.0,
933,283895,6,2,,103184924,3213,Active,,,5.01,IC50,Cytotoxicity against human HT1080 cells after 3 days by SRB assay,Confirmatory,17035025.0,
934,283896,6,2,,103184924,3213,Active,,,2.6,IC50,Cytotoxicity against human HL60 cells after 3 days by SRB assay,Confirmatory,17035025.0,
935,287087,6,2,,103184924,3213,Active,,,5.3,IC50,Cytotoxicity against KB cells by colorimetric method,Confirmatory,17480099.0,
936,287088,6,3,,103184924,3213,Active,,,6.1,IC50,Cytotoxicity against BC cells by colorimetric method,Confirmatory,17480099.0,
937,291420,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,17567069.0,
938,291421,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells,Other,17567069.0,
939,299306,6,2,,103184924,3213,Active,,,1.9,IC50,Cytotoxicity against human A549 cells by SRB assay,Confirmatory,17498951.0,
940,299307,6,2,,103184924,3213,Active,,,2.3,IC50,Cytotoxicity against human Col2 cells by SRB assay,Confirmatory,17498951.0,
941,299308,6,3,,103184924,3213,Active,,,2.2,IC50,Cytotoxicity against human SNU638 cells by SRB assay,Confirmatory,17498951.0,
942,299309,6,2,,103184924,3213,Active,,,4.3,IC50,Cytotoxicity against human HT1080 cells by SRB assay,Confirmatory,17498951.0,
943,299310,6,2,,103184924,3213,Active,,,5.8,IC50,Cytotoxicity against human HL60 cells by MTT assay,Confirmatory,17498951.0,
944,299311,3,9,,103184924,3213,Inconclusive,12644118.0,7150.0,,,Inhibition of human topoisomerase 1 using supercoiled pBR32 DNA substrate,Other,17498951.0,
945,307115,6,2,,103184924,3213,Active,,,0.3,IC50,Growth inhibition of human HCT116 cells by MTT assay,Confirmatory,17376678.0,
946,307116,6,2,,103184924,3213,Active,,,0.003,IC50,Growth inhibition of mouse NIH3T3 cells by MTT assay,Confirmatory,17376678.0,
947,307117,3,3,,103184924,3213,Active,,,,,Inhibition of topoisomerase 2-mediated kDNA de-catenation,Other,17376678.0,
948,311488,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,17845001.0,
949,311489,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells,Other,17845001.0,
950,311490,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells,Other,17845001.0,
951,311559,6,2,,103184924,3213,Active,,,2.03,IC50,Cytotoxicity against African green monkey Vero cells after 72 hrs,Confirmatory,17892262.0,
952,325529,7,2,,103184924,3213,Active,,,18.5,IC50,Inhibition of p56lck autophosphorylation,Confirmatory,18077363.0,
953,325554,9,1,,103184924,3213,Active,,,3.3,IC50,Inhibition of topoisomerase 2,Confirmatory,18077363.0,
954,325555,4,3,,103184924,3213,Active,,,15.0,IC50,Growth inhibition of v-ras transformed human bronchial cells,Confirmatory,18077363.0,
955,327682,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells,Other,18179177.0,
956,327683,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,18179177.0,
957,327684,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human breast cancer cells,Other,18179177.0,
958,333842,6,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,7130986.0,
959,336140,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells,Other,12350163.0,
960,336141,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,12350163.0,
961,337648,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Lu1 cells after 3 days by SRB assay,Other,7528785.0,
962,337649,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells after 3 days by SRB assay,Other,7528785.0,
963,337650,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KBVIN cells in presence of 1 ug/ml vinblastine after 3 days by SRB assay,Other,7528785.0,
964,337651,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KBVIN cells after 3 days by SRB assay,Other,7528785.0,
965,337652,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human LNCAP cells after 3 days by SRB assay,Other,7528785.0,
966,337653,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human ZR-75-1 cells after 3 days by SRB assay,Other,7528785.0,
967,337654,3,5,,103184924,3213,Inactive,,,,,Cytotoxicity against human ASK cells after 3 days by SRB assay,Other,7528785.0,
968,355812,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Lu1 cells,Other,12762797.0,
969,355813,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Col2 cells,Other,12762797.0,
970,355814,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,12762797.0,
971,355815,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human LNCAP cells,Other,12762797.0,
972,356038,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,12828479.0,
973,356039,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells,Other,12828479.0,
974,356040,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells,Other,12828479.0,
975,357313,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,11520217.0,
976,357314,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells by SRB assay,Other,11520217.0,
977,357845,4,4,,103184924,3213,Unspecified,,,,,Binding affinity to calf thymus DNA assessed as reduction in DNA peak by pre-incubation method,Other,1812211.0,
978,357846,4,4,,103184924,3213,Unspecified,,,,,Binding affinity to yeast tRNA assessed as reduction in tRNA peak by pre-incubation method,Other,1812211.0,
979,359199,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,11277765.0,
980,359200,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells by SRB assay,Other,11277765.0,
981,359201,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by SRB assay,Other,11277765.0,
982,377084,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,15730240.0,
983,377085,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells,Other,15730240.0,
984,377086,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells,Other,15730240.0,
985,377921,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by MTT assay,Other,16792425.0,
986,377922,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells by MTT assay,Other,16792425.0,
987,377937,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells after 72 hrs by SRB assay,Other,9917280.0,
988,377938,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human HCT-15 cells after 72 hrs by SRB assay,Other,9917280.0,
989,378431,10,1,,103184924,3213,Active,,,0.812,IC50,Cytotoxicity against human KB cells by SRB assay,Confirmatory,16933890.0,
990,378432,10,1,,103184924,3213,Active,,,0.682,IC50,Cytotoxicity against human BC cells by SRB assay,Confirmatory,16933890.0,
991,378433,10,2,,103184924,3213,Active,,,2.23,IC50,Cytotoxicity against human NCI-H187 cells by SRB assay,Confirmatory,16933890.0,
992,378790,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by colorimetric method,Other,16989536.0,
993,378791,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells by colorimetric method,Other,16989536.0,
994,378810,6,2,,103184924,3213,Active,,,5.41,IC50,Cytotoxicity against human KB cells by colorimetric method,Confirmatory,17067151.0,
995,378811,6,3,,103184924,3213,Active,,,5.93,IC50,Cytotoxicity against human BC1 cells by colorimetric method,Confirmatory,17067151.0,
996,378812,6,3,,103184924,3213,Active,,,1.59,IC50,Cytotoxicity against human NCI-H187 cells by colorimetric method,Confirmatory,17067151.0,
997,378984,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells,Other,16441071.0,
998,378986,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,16441071.0,
999,378987,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC clls,Other,16441071.0,
1000,379145,5,1,,103184924,3213,Unspecified,,,,,Toxicity against human KB cells,Other,17067158.0,
1001,379146,5,1,,103184924,3213,Unspecified,,,,,Toxicity against mouse P388 cells,Other,17067158.0,
1002,379147,5,1,,103184924,3213,Unspecified,,,,,Toxicity against human SQC1 UISO cells,Other,17067158.0,
1003,379919,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against mouse P388 cells by SRB assay,Other,17190450.0,
1004,379920,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,17190450.0,
1005,379921,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Col2 cells by SRB assay,Other,17190450.0,
1006,379922,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BCA1 cells by SRB assay,Other,17190450.0,
1007,379923,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Lu1 cells by SRB assay,Other,17190450.0,
1008,379924,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against mouse ASK cells by SRB assay,Other,17190450.0,
1009,380093,6,2,,103184924,3213,Active,,,2.44,IC50,Cytotoxicity against african green monkey Vero cells,Confirmatory,16499340.0,
1010,380832,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human SQC1 cells after 72 hrs by SRB method,Other,10479311.0,
1011,380833,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells after 72 hrs by SRB method,Other,10479311.0,
1012,380834,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human OVCAR cells after 72 hrs by SRB method,Other,10479311.0,
1013,380835,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human HCT-15 cells after 72 hrs by SRB method,Other,10479311.0,
1014,383714,6,2,,103184924,3213,Active,,,1.99,IC50,Cytotoxicity against human KB cells by colorimetric method,Confirmatory,18363379.0,
1015,383715,6,3,,103184924,3213,Active,,,0.49,IC50,Cytotoxicity against human BC cells by colorimetric method,Confirmatory,18363379.0,
1016,383716,6,3,,103184924,3213,Active,,,1.71,IC50,Cytotoxicity against human NCI-H187 cells by colorimetric method,Confirmatory,18363379.0,
1017,383717,6,2,,103184924,3213,Active,,,1.94,IC50,Cytotoxicity against African green monkey Vero cells by colorimetric method,Confirmatory,18363379.0,
1018,383952,6,2,,103184924,3213,Inconclusive,,,,IC50,Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 by microculture radioisotope technique,Confirmatory,18380478.0,
1019,383954,6,2,,103184924,3213,Active,,,2.2,IC50,Cytotoxicity against human KB cells by colorimetric method,Confirmatory,18380478.0,
1020,383955,6,3,,103184924,3213,Active,,,1.2,IC50,Cytotoxicity against human BC cells by colorimetric method,Confirmatory,18380478.0,
1021,383956,6,3,,103184924,3213,Active,,,2.0,IC50,Cytotoxicity against human NCI-H187 cells by colorimetric method,Confirmatory,18380478.0,
1022,383957,6,2,,103184924,3213,Active,,,2.1,IC50,Cytotoxicity against african green monkey Vero cells by colorimetric method,Confirmatory,18380478.0,
1023,384922,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against mouse P388 cells after 72 hrs by sulforhodamine B assay,Other,18271551.0,
1024,384923,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay,Other,18271551.0,
1025,384924,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Col2 cells after 72 hrs by sulforhodamine B assay,Other,18271551.0,
1026,384925,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B assay,Other,18271551.0,
1027,385089,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Lu1 cells after 72 hrs by sulforhodamine B assay,Other,18271551.0,
1028,385090,5,1,,103184924,3213,Unspecified,,,,,Cytotoxicity against rat ASK cells after 72 hrs by sulforhodamine B assay,Other,18271551.0,
1029,388883,3,9,,103184924,3213,Active,13959709.0,7153.0,,,Inhibition of human topoisomerase 2 alpha-mediated bacterial plasmid DNA relaxation assessed as pRYG negative supercoiled form at 100 uM,Other,18816045.0,
1030,388884,3,9,,103184924,3213,Inactive,13959709.0,7153.0,,,Inhibition of human topoisomerase 2 alpha-mediated bacterial plasmid DNA relaxation assessed as pRYG negative supercoiled form added 100 uM after relaxation,Other,18816045.0,
1031,388885,3,3,,103184924,3213,Active,,,,,DNA intercalative activity assessed retardation in migration of negatively supercoiled small circular Escherichia coli pBSKS in agarose gel electrophoresis at 100 uM,Other,18816045.0,
1032,397122,6,3,,103184924,3213,Unspecified,,,,,Inhibition of HIV1 RT,Other,1710653.0,
1033,399044,7,2,,103184924,3213,Inconclusive,,,,,Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 after 42 hrs by [3H]hypoxanthine uptake,Other,16309322.0,
1034,399045,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,16309322.0,
1035,399046,7,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells by SRB assay,Other,16309322.0,
1036,399047,7,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by SRB assay,Other,16309322.0,
1037,399048,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by SRB assay,Other,16309322.0,
1038,399554,6,3,,103184924,3213,Active,,,0.08,CC50,Cytotoxicity against human HOG.R5 cells,Confirmatory,14987058.0,
1039,399555,9,1,,103184924,3213,Active,,,0.16,IC50,Cytotoxicity against human KB cells,Confirmatory,14987058.0,
1040,399556,9,1,,103184924,3213,Active,,,1.22,IC50,Cytotoxicity against human Col2 cells,Confirmatory,14987058.0,
1041,399557,9,1,,103184924,3213,Active,,,3.25,IC50,Cytotoxicity against human LNCAP cells,Confirmatory,14987058.0,
1042,399558,9,1,,103184924,3213,Active,,,0.08,IC50,Cytotoxicity against human Lu1 cells,Confirmatory,14987058.0,
1043,399559,9,1,,103184924,3213,Active,,,0.37,IC50,Cytotoxicity against HUVEC,Confirmatory,14987058.0,
1044,400591,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells by SRB assay,Other,15043440.0,
1045,400593,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,15043440.0,
1046,400594,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by SRB assay,Other,15043440.0,
1047,402573,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells,Other,15217275.0,
1048,402575,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells,Other,15217275.0,
1049,402577,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells,Other,15217275.0,
1050,402638,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by colorimetric method,Other,16038539.0,
1051,402639,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells by colorimetric method,Other,16038539.0,
1052,402640,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by colorimetric method,Other,16038539.0,
1053,402724,6,3,,103184924,3213,Active,,,0.8,IC50,Cytotoxicity against human NCI-H187 cells,Confirmatory,16038559.0,
1054,402726,6,3,,103184924,3213,Active,,,0.8,IC50,Cytotoxicity against human BC cells,Confirmatory,16038559.0,
1055,402728,6,2,,103184924,3213,Active,,,0.8,IC50,Cytotoxicity against human KB cells,Confirmatory,16038559.0,
1056,402730,6,2,,103184924,3213,Active,,,0.8,IC50,Cytotoxicity against african green monkey Vero cells,Confirmatory,16038559.0,
1057,404055,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by colorimetric assay,Other,16378377.0,
1058,404056,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC cells by colorimetric assay,Other,16378377.0,
1059,404057,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by colorimetric assay,Other,16378377.0,
1060,407490,9,1,,103184924,3213,Unspecified,,,90.0,IC50,Inhibition of glucocorticoid receptor-glucocorticoid complex transfected in rat R1 cells assessed as down-regulation of TPA-responsive element proinflammatory gene expression after 24 hrs by beta-galactosidase assay,Confirmatory,18412397.0,
1061,407493,3,4,,103184924,3213,Unspecified,,,,,Cytotoxicity against rat R1 cells at 100 uM after 24 hrs by neutral red assay,Other,18412397.0,
1062,423412,7,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human Hep2 cells after 72 hrs by sulforhodamine B assay,Other,19265396.0,
1063,423413,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay,Other,19265396.0,
1064,423414,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human HeLa cells after 72 hrs by sulforhodamine B assay,Other,19265396.0,
1065,423419,6,2,,103184924,3213,Active,,,1.38,IC50,Cytotoxicity against human KB cells by SRB assay,Confirmatory,19265430.0,
1066,423420,6,3,,103184924,3213,Active,,,1.2,IC50,Cytotoxicity against human BC cells by SRB assay,Confirmatory,19265430.0,
1067,423421,6,3,,103184924,3213,Active,,,4.4,IC50,Cytotoxicity against human NCI-H187 cells by SRB assay,Confirmatory,19265430.0,
1068,423422,6,2,,103184924,3213,Active,,,1.69,IC50,Cytotoxicity against african green monkey Vero cells by SRB assay,Confirmatory,19265430.0,
1069,425026,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by sulforhodamine B assay,Other,19368377.0,
1070,425027,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by sulforhodamine B assay,Other,19368377.0,
1071,425028,7,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells by sulforhodamine B assay,Other,19368377.0,
1072,425029,7,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by sulforhodamine B assay,Other,19368377.0,
1073,426105,6,2,,103184924,3213,Active,,,0.66,IC50,Antiproliferative activity against human HL60 cells after 72 hrs by trypan blue assay,Confirmatory,19155103.0,
1074,426106,6,2,,103184924,3213,Active,,,0.29,IC50,Antiproliferative activity against human HeLa cells after 72 hrs by trypan blue assay,Confirmatory,19155103.0,
1075,426107,6,3,,103184924,3213,Active,,,1.1,IC50,Antiproliferative activity against human JR8 cells after 72 hrs by trypan blue assay,Confirmatory,19155103.0,
1076,426108,3,3,,103184924,3213,Active,,,,,Binding affinity to salmon testes DNA assessed as occurrence of intercalative molecular complex by linear flow dichroism,Other,19155103.0,
1077,426316,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by sulforhodamine B assay,Other,19555123.0,
1078,426317,7,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by sulforhodamine B assay,Other,19555123.0,
1079,427231,7,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay,Other,19456117.0,
1080,427610,6,2,,103184924,3213,Active,,,0.43,IC50,Cytotoxicity against human MCF7 cells after 96 hrs by crystal violet staining,Confirmatory,19481463.0,
1081,427611,6,3,,103184924,3213,Active,,,0.8,IC50,Cytotoxicity against human LCLC-103H cells after 96 hrs by crystal violet staining,Confirmatory,19481463.0,
1082,427612,6,2,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human DAN-G cells after 96 hrs by crystal violet staining,Confirmatory,19481463.0,
1083,427613,6,3,,103184924,3213,Active,,,1.21,IC50,Cytotoxicity against human RT4 cells after 96 hrs by crystal violet staining,Confirmatory,19481463.0,
1084,427614,6,2,,103184924,3213,Active,,,0.89,IC50,Cytotoxicity against human A427 cells after 96 hrs by crystal violet staining,Confirmatory,19481463.0,
1085,427615,6,2,,103184924,3213,Active,,,0.89,IC50,Cytotoxicity against human 5637 cells after 96 hrs by crystal violet staining,Confirmatory,19481463.0,
1086,427929,6,2,,103184924,3213,Active,,,0.29,IC50,Cytotoxicity against human HeLa cells after 72 hrs by trypan blue assay,Confirmatory,19725581.0,
1087,427930,6,2,,103184924,3213,Active,,,0.66,IC50,Cytotoxicity against human HL60 cells after 72 hrs by trypan blue assay,Confirmatory,19725581.0,
1088,434955,1,2,,855686,3213,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
1089,434959,1,1,,85787856,3213,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
1090,434962,1,2,,855686,3213,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
1091,434973,1,3,,855686,3213,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
1092,434989,1,1,,855686,3213,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
1093,435003,1,3,,855686,3213,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
1094,435005,1,1,,855686,3213,Active,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
1095,435006,1,2,,855686,3213,Active,219518789.0,114548.0,,,Single concentration confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay,Screening,,
1096,435014,1,1,,855686,3213,Active,13928834.0,50599.0,3.0789999999999997,FitEC50,Measurement of GPCR-mediated thallium flux through GIRK channels: Dose-Response Testing,Confirmatory,,
1097,435022,2,2,,855686,3213,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
1098,435030,1,2,,855686,3213,Active,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
1099,435030,1,2,,855686,3213,Active,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
1100,449728,1,2,,855686,3213,Active,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
1101,449739,1,2,,855686,3213,Active,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
1102,449756,1,1,,855686,3213,Active,,,2.124,AC50_uM,Luminescence Cell-Based Dose Retest to Confirm Inhibitors of  Beta Cell Apoptosis,Confirmatory,,
1103,449762,1,2,,855686,3213,Inconclusive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
1104,449763,1,3,,855686,3213,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
1105,449768,1,1,,855686,3213,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
1106,453794,4,8,,103184924,3213,Active,13959709.0,7153.0,,,Inhibition of human topoisomerase 2alpha-mediated relaxation of double-stranded pRYG DNA at 100 uM by agarose gel electrophoresis,Other,19783445.0,
1107,453795,3,3,,103184924,3213,Active,,,,,Induction of DNA intercalation in pRYG DNA at 100 uM by agarose gel electrophoresis,Other,19783445.0,
1108,453796,4,3,,103184924,3213,Inactive,,,,,Inhibition of Xanthomonas vasicola XhoI assessed as pBSKS cleavage at 100 uM by endonuclease assay,Other,19783445.0,
1109,463073,1,2,,855686,3213,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4),Screening,,
1110,463075,1,1,,855686,3213,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
1111,463079,1,2,,855686,3213,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
1112,463082,1,1,,855686,3213,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
1113,463096,1,1,,50104008,3213,Inconclusive,,,25.1189,Potency,Validation screen for inhibitors of Lassa infection,Confirmatory,,
1114,463097,1,1,,50104008,3213,Active,7705682.0,51053.0,7.0795,Potency,Validation screen for small molecules that induce DNA re-replication in MCF 10A normal breast cells,Confirmatory,,
1115,463104,1,2,,855686,3213,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
1116,463106,1,2,,90341166,3213,Inactive,188528692.0,9099.0,,Potency,qHTS Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
1117,463111,1,1,,855686,3213,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
1118,463115,1,1,,855686,3213,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
1119,463141,1,2,,855686,3213,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
1120,463165,1,1,,855686,3213,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
1121,463187,1,1,,855686,3213,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
1122,463189,1,1,,855686,3213,Active,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
1123,463189,1,1,,53777637,3213,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
1124,463190,1,2,,855686,3213,Active,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
1125,463193,1,1,,855686,3213,Active,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
1126,463195,1,2,,855686,3213,Active,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
1127,463206,1,1,,855686,3213,Active,,,1.11,AC50_uM,Luminescence Cell-Based Counter Screen to Identify Inhibitors of Cytokine Induced Apoptosis,Confirmatory,,
1128,463210,1,2,,855686,3213,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
1129,463212,1,1,,855686,3213,Active,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
1130,463213,1,3,,855686,3213,Inactive,285809906.0,856395.0,,,Single concentration confirmation of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
1131,463215,1,2,,855686,3213,Active,285809906.0,856395.0,,,Single concentration confirmation of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
1132,463218,1,2,,855686,3213,Active,285814664.0,855751.0,,,Single concentration confirmation of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
1133,463229,1,1,,855686,3213,Active,,,5.212000000000001,AC50_uM,ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick,Confirmatory,,
1134,463254,1,1,,855686,3213,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
1135,464249,5,2,,103184924,3213,Active,,,1.75,IC50,Cytotoxicity against African green monkey Vero cells by SRB assay,Confirmatory,20038128.0,
1136,468245,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells by SRB assay,Other,19627125.0,
1137,468246,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,19627125.0,
1138,468247,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by SRB assay,Other,19627125.0,
1139,469260,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by SRB assay,Other,19778068.0,
1140,469261,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,19778068.0,
1141,469263,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by SRB assay,Other,19778068.0,
1142,470177,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by sulforhodamine B assay,Other,19943622.0,
1143,470210,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by SRB assay,Other,19663417.0,
1144,470211,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human BC1 cells by SRB assay,Other,19663417.0,
1145,470212,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by SRB assay,Other,19663417.0,
1146,470213,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU100 cells by MTT assay,Other,19663417.0,
1147,470214,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M139 cells by MTT assay,Other,19663417.0,
1148,470215,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M156 cells by MTT assay,Other,19663417.0,
1149,470216,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M213 cells by MTT assay,Other,19663417.0,
1150,470217,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M214 cells by MTT assay,Other,19663417.0,
1151,471995,5,3,,103184924,3213,Active,,,3.6,IC50,Cytotoxicity against human NCI-H187 cells by resazurin microplate assay,Confirmatory,19739600.0,
1152,471996,5,2,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human MCF7 cells by resazurin microplate assay,Confirmatory,19739600.0,
1153,471997,5,2,,103184924,3213,Active,,,2.5,IC50,Cytotoxicity against human KB cells by resazurin microplate assay,Confirmatory,19739600.0,
1154,471998,5,2,,103184924,3213,Active,,,5.5,IC50,Cytotoxicity against african green monkey Vero cells after 8 days by green fluorescent protein microplate assay,Confirmatory,19739600.0,
1155,477971,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by resazurin microplate assay,Other,20329738.0,
1156,477973,6,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human NCI-H187 cells by resazurin microplate assay,Other,20329738.0,
1157,477974,6,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells by green fluorescent protein assay,Other,20329738.0,
1158,478102,5,3,,103184924,3213,Active,,,1.5,IC50,Cytotoxicity against human NCI-H187 cells after 45 hrs by resazurin microplate assay,Confirmatory,20364867.0,
1159,478104,5,2,,103184924,3213,Active,,,2.5,IC50,Cytotoxicity against human KB cells after 45 hrs by resazurin microplate assay,Confirmatory,20364867.0,
1160,478105,5,2,,103184924,3213,Active,,,3.8,IC50,Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay,Confirmatory,20364867.0,
1161,480465,5,2,,103184924,3213,Active,,,1.79,IC50,Cytotoxicity against human KB cells after 3 days by Resazurin Microplate Assay,Confirmatory,20362442.0,
1162,480467,5,3,,103184924,3213,Active,,,2.77,IC50,Cytotoxicity against human NCI-H187 cells after 5 days by Resazurin Microplate Assay,Confirmatory,20362442.0,
1163,480469,5,2,,103184924,3213,Active,,,2.29,IC50,Cytotoxicity against african green monkey Vero cells by green fluorescent protein based assay,Confirmatory,20362442.0,
1164,485270,1,1,,855686,3213,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
1165,485272,1,1,,855686,3213,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
1166,485273,2,1,,855686,3213,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
1167,485275,1,3,,855686,3213,Active,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
1168,485281,1,1,,855686,3213,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
1169,485281,1,1,,11111147,3213,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
1170,485290,1,1,,855686,3213,Active,20150581.0,,50.1187,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1171,485290,1,1,,11111147,3213,Inconclusive,20150581.0,,6.3096,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1172,485290,1,1,,50104008,3213,Inconclusive,20150581.0,,14.1254,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1173,485294,1,1,,855686,3213,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
1174,485295,1,2,,90341166,3213,Inconclusive,30027657.0,,23.7781,Potency,qHTS Validation Assay for the Inhibitors of DNA Replication in Gram-Positive Bacteria,Confirmatory,,
1175,485297,1,1,,855686,3213,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
1176,485297,1,1,,90341166,3213,Inactive,4759012.0,9367.0,46.1091,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
1177,485298,1,1,,855686,3213,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
1178,485298,1,1,,90341166,3213,Inconclusive,,,14.581,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
1179,485313,1,2,,855686,3213,Inactive,255652944.0,4864.0,3.1623,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
1180,485313,1,2,,90341166,3213,Inactive,255652944.0,4864.0,58.0479,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
1181,485314,1,1,,855686,3213,Active,4505931.0,5423.0,3.9811,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
1182,485314,1,1,,50104008,3213,Active,4505931.0,5423.0,15.8489,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
1183,485317,1,2,,855686,3213,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
1184,485341,1,1,,855686,3213,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
1185,485342,1,2,,90341166,3213,Inactive,5454140.0,7251.0,,Potency,qHTS Validation Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
1186,485344,1,1,,855686,3213,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
1187,485345,1,2,,90341166,3213,Inconclusive,,,2.0596,Potency,qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
1188,485346,1,1,,855686,3213,Active,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1189,485346,1,1,,855686,3213,Active,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1190,485347,1,2,,855686,3213,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
1191,485349,1,1,,855686,3213,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
1192,485350,1,2,,92125514,3213,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
1193,485353,2,1,,855686,3213,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
1194,485358,1,1,,855686,3213,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
1195,485360,1,1,,855686,3213,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
1196,485364,1,1,,855686,3213,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
1197,485366,1,2,,90341166,3213,Inactive,4501969.0,154.0,,Potency,qHTS validation assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
1198,485367,1,2,,855686,3213,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
1199,485368,1,2,,90341166,3213,Inconclusive,72386991.0,3656265.0,8.4921,Potency,qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
1200,488745,1,4,,85231031,3213,Active,,,1.1689,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1201,488752,1,4,,85231031,3213,Active,,,1.8526,Potency,"Quantitative high throughput screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1202,488772,1,1,,90341166,3213,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
1203,488773,1,2,,90341166,3213,Inconclusive,8659577.0,58819.0,29.9349,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1),Confirmatory,,
1204,488784,1,2,,855686,3213,Active,219518789.0,114548.0,,,Single concentration confirmation of inhibitors of NALP3 in yeast using a Caspase-1-ASC counter screen,Screening,,
1205,488794,1,2,,855686,3213,Inactive,219518789.0,114548.0,,,Single concentration confirmation of uHTS for the identification of inhibitors of NALP3 in yeast using a luminescent assay - retest,Screening,,
1206,488806,1,2,,855686,3213,Inactive,148539876.0,156.0,,,RNA aptamer-based validation for inhibitors of GRK2,Screening,,
1207,488816,1,1,,90341166,3213,Active,4758356.0,2237.0,10.6213,Potency,qHTS Validation Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1),Confirmatory,,
1208,488837,1,1,,855686,3213,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
1209,488837,1,1,,90341166,3213,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
1210,488839,1,1,,56424143,3213,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1211,488839,1,1,,56424143,3213,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1212,488847,1,3,,855686,3213,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
1213,488862,1,1,,56424143,3213,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1214,488890,1,2,,855686,3213,Inconclusive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
1215,488895,1,2,,56424143,3213,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1216,488896,1,1,,56424143,3213,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1217,488899,1,1,,56424143,3213,Active,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1218,488922,1,2,,855686,3213,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
1219,488942,1,1,,855686,3213,Inactive,15645703.0,899625.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex,Screening,,
1220,488942,1,1,,855686,3213,Inactive,15646160.0,899738.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex,Screening,,
1221,488949,1,2,,85231031,3213,Inactive,41055989.0,54737.0,0.631,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1222,488949,1,2,,90341166,3213,Inactive,41055989.0,54737.0,,Potency,qHTS Validation Assay for Inhibitors for MPP8 Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1223,488953,1,1,,90341166,3213,Active,187960037.0,10951.0,50.1187,Potency,qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1224,488955,1,1,,855686,3213,Inactive,16130723.0,947287.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
1225,488955,1,1,,855686,3213,Inactive,16130724.0,947286.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
1226,488955,1,1,,855686,3213,Inactive,16130726.0,947294.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
1227,488956,1,1,,855686,3213,Inactive,,,,,Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability,Screening,,
1228,488965,1,2,,56424143,3213,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1229,488966,1,1,,56424143,3213,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
1230,488975,1,2,,855686,3213,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
1231,488977,1,2,,855686,3213,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
1232,488978,1,1,,90341166,3213,Inactive,45359078.0,,,Potency,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity: MmCpn Primary Screen,Confirmatory,,
1233,488979,1,1,,50104008,3213,Inactive,74315350.0,7442.0,,Potency,HTS Assay for Compounds that Act as Enhancers of the Vanilloid Receptor 1,Confirmatory,,
1234,488980,1,1,,85231031,3213,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Antagonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
1235,488981,1,1,,90341166,3213,Active,4503383.0,1812.0,10.0,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Agonists,Confirmatory,,
1236,488982,1,1,,90341166,3213,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Potentiators,Confirmatory,,
1237,488983,1,1,,90341166,3213,Inactive,4503383.0,1812.0,,Potency,HTS Assay for Allosteric Agonists of the Human D1 Dopamine Receptor: Primary Screen for Antagonists,Confirmatory,,
1238,489005,1,2,,855686,3213,Active,53832009.0,8912.0,3.99,EC50_1,Inhibitors of T-Type Calcium Channel,Confirmatory,,
1239,489007,1,1,,855686,3213,Inconclusive,20150581.0,,31.6228,Potency,Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1240,489028,1,2,,855686,3213,Active,88702791.0,4194.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1241,489028,1,2,,855686,3213,Active,89993689.0,4193.0,,,Single concentration confirmation of uHTS for Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1242,489030,2,1,,855686,3213,Active,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
1243,489031,2,1,,855686,3213,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
1244,492428,7,1,,103184924,3213,Active,,,0.073,IC50,Antimalarial activity against multidrug-resistant Plasmodium falciparum K1,Confirmatory,19299148.0,
1245,492947,1,1,,855686,3213,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
1246,492953,1,1,,56424143,3213,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
1247,492956,1,1,,56424143,3213,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
1248,492967,1,2,,92125514,3213,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
1249,492972,1,1,,56424143,3213,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
1250,493005,1,1,,56424143,3213,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
1251,493008,1,1,,56424143,3213,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1252,493008,1,1,,56424143,3213,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1253,493008,1,1,,56424143,3213,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1254,493008,1,1,,56424143,3213,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1255,493011,1,1,,855686,3213,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1256,493012,1,1,,855686,3213,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1257,493014,1,1,,855686,3213,Inconclusive,,,5.8048,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
1258,493027,1,2,,56424143,3213,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1259,493027,1,2,,56424143,3213,Inactive,223718203.0,5346.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1260,493033,1,2,,92125514,3213,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
1261,493035,1,2,,56424143,3213,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1262,493035,1,2,,56424143,3213,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1263,493036,1,2,,855686,3213,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
1264,493056,1,1,,855686,3213,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
1265,493084,1,1,,855686,3213,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
1266,493087,1,1,,56424143,3213,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
1267,493091,1,1,,56424143,3213,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
1268,493098,1,1,,56424143,3213,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
1269,493106,1,1,,90341166,3213,Inactive,116283940.0,79915.0,32.6294,Potency,Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1270,493107,1,1,,90341166,3213,Active,116283940.0,79915.0,16.3535,Potency,Validation screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1271,493127,1,1,,50104008,3213,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Validation Screen for Agonists,Screening,,
1272,493131,1,1,,56424143,3213,Active,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
1273,493140,1,1,,103913774,3213,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
1274,493153,1,1,,90341166,3213,Inconclusive,,4780.0,10.3225,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
1275,493153,1,1,,90341166,3213,Inconclusive,224028257.0,4780.0,10.3225,Potency,Nrf2 qHTS screen for inhibitors: Validation,Confirmatory,,
1276,493160,1,1,,56424143,3213,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
1277,493164,1,2,,90341166,3213,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1278,493164,1,2,,90341166,3213,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1279,493164,1,2,,90341166,3213,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation: Validation Assay,Confirmatory,,
1280,493187,1,2,,56424143,3213,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
1281,493189,1,1,,50104008,3213,Inactive,4503895.0,2584.0,,Potency,qHTS Validation Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
1282,493244,1,1,,56424143,3213,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1283,493244,1,1,,56424143,3213,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1284,493244,1,1,,56424143,3213,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1285,493244,1,1,,56424143,3213,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1286,499774,4,2,,103184924,3213,Active,,,1.6,IC50,Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay,Confirmatory,20667744.0,
1287,499775,4,2,,103184924,3213,Active,,,3.4,IC50,Cytotoxicity against human A549 cells after 72 hrs by MTT assay,Confirmatory,20667744.0,
1288,499776,4,2,,103184924,3213,Unspecified,,,10.0,IC50,Cytotoxicity against human HDF after 72 hrs by MTT assay,Confirmatory,20667744.0,
1289,504300,4,2,,103184924,3213,Active,,,1.1,IC50,Cytotoxicity against human KB cells,Confirmatory,20815366.0,
1290,504302,4,2,,103184924,3213,Active,,,4.47,IC50,Cytotoxicity against african green monkey Vero cells,Confirmatory,20815366.0,
1291,504326,1,2,,56424143,3213,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1292,504326,1,2,,56424143,3213,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1293,504327,1,1,,855686,3213,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1294,504327,1,1,,11111147,3213,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1295,504327,1,1,,90341166,3213,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1296,504329,1,1,,56424143,3213,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
1297,504332,1,1,,855686,3213,Inconclusive,168985070.0,,39.8107,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1298,504332,1,1,,11111147,3213,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1299,504332,1,1,,50104008,3213,Inactive,168985070.0,,11.2202,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1300,504332,1,1,,90341166,3213,Active,168985070.0,,21.1923,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1301,504333,1,1,,855686,3213,Active,6683500.0,29994.0,56.2341,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
1302,504339,1,1,,56424143,3213,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
1303,504357,1,1,,56424143,3213,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1304,504357,1,1,,56424143,3213,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1305,504364,1,1,,85231031,3213,Inconclusive,7705682.0,51053.0,9.2,Potency,Validation screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells,Confirmatory,,
1306,504406,1,1,,855686,3213,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
1307,504408,2,1,,855686,3213,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
1308,504411,1,1,,56424143,3213,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
1309,504414,1,1,,56424143,3213,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1310,504414,1,1,,56424143,3213,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1311,504423,1,1,,56424143,3213,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1312,504441,1,1,,56424143,3213,Active,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1313,504444,1,1,,56424143,3213,Active,224028257.0,4780.0,7.3078,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
1314,504454,1,3,,56424143,3213,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
1315,504459,1,3,,855686,3213,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method from Validation Set,Screening,,
1316,504462,1,1,,56424143,3213,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
1317,504466,1,1,,855686,3213,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1318,504467,1,1,,855686,3213,Inconclusive,116283940.0,79915.0,12.9953,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1319,504490,1,2,,56424143,3213,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
1320,504523,1,1,,56424143,3213,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1321,504523,1,1,,56424143,3213,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1322,504536,1,1,,90341166,3213,Inactive,5453898.0,5300.0,,Potency,qHTS Validation Assay to Find Inhibitors of Pin1,Confirmatory,,
1323,504541,1,1,,855686,3213,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction for Validation Set,Screening,,
1324,504547,1,1,,90341166,3213,Inactive,115503961.0,4357161.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1325,504548,1,2,,90341166,3213,Inactive,157877932.0,5655980.0,,Potency,qHTS Validation Assay to Find Inhibitors of Phosphoglycerate Mutase,Confirmatory,,
1326,504558,1,1,,56424143,3213,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1327,504577,2,2,,56424143,3213,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1328,504582,2,1,,56424143,3213,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1329,504594,1,1,,56424143,3213,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1330,504600,1,2,,855686,3213,Inactive,6325022.0,855842.0,,,Validation of HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1331,504607,1,1,,855686,3213,Inactive,,,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay,Screening,,
1332,504614,1,1,,855686,3213,Inactive,187952397.0,317.0,,,Single concentration confirmation of uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
1333,504615,1,1,,855686,3213,Inactive,187952397.0,317.0,,,uHTS Fluorescent Interference Counterscreen assay for validation of Inhibitors of Apaf-1,Screening,,
1334,504621,1,1,,56424143,3213,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1335,504634,1,1,,56424143,3213,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1336,504648,1,1,,56424143,3213,Inconclusive,,,23.1093,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
1337,504651,1,1,,855686,3213,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
1338,504652,1,1,,855686,3213,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
1339,504660,1,1,,855686,3213,Active,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
1340,504668,1,1,,855686,3213,Inactive,728984.0,672.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
1341,504668,1,1,,855686,3213,Inactive,116241265.0,580.0,,,Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay.,Screening,,
1342,504690,1,3,,56424143,3213,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
1343,504692,2,2,,56424143,3213,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1344,504700,1,1,,56424143,3213,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1345,504700,1,1,,56424143,3213,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1346,504706,1,1,,855686,3213,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
1347,504707,1,1,,56424143,3213,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1348,504707,1,1,,56424143,3213,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1349,504720,1,1,,56424143,3213,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
1350,504734,1,1,,56424143,3213,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
1351,504766,2,1,,56424143,3213,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
1352,504775,1,1,,56424143,3213,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
1353,504803,1,1,,56424143,3213,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
1354,504810,1,2,,855686,3213,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1355,504810,1,2,,90341166,3213,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1356,504812,1,2,,855686,3213,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1357,504812,1,2,,90341166,3213,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1358,504821,1,1,,85231031,3213,Inactive,38016895.0,7253.0,,Potency,Antagonists of the Thyroid Stimulating Hormone Receptor: Validation,Confirmatory,,
1359,504832,1,1,,855686,3213,Active,,,1.0418,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1360,504834,1,1,,855686,3213,Active,,,1.0418,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1361,504836,1,2,,90341166,3213,Inactive,168984549.0,,,Potency,Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation,Confirmatory,11836247.0,
1362,504842,1,1,,855686,3213,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
1363,504845,1,1,,56424143,3213,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1364,504845,1,1,,90341166,3213,Inactive,86301163.0,5999.0,1.6834,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1365,504847,1,1,,11111147,3213,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1366,504847,1,1,,56424143,3213,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1367,504847,1,1,,90341166,3213,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1368,504865,1,1,,11111147,3213,Inconclusive,118600387.0,7398.0,7.0795,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
1369,504865,1,1,,90341166,3213,Inconclusive,118600387.0,7398.0,79.4328,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
1370,504884,1,2,,56424143,3213,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1371,504891,1,1,,56424143,3213,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
1372,504894,1,1,,56424143,3213,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
1373,504937,1,2,,56424143,3213,Inactive,179095.0,6609.0,25.1189,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
1374,511835,4,3,,103184924,3213,Active,,,25.21,IC50,Cytotoxicity against human KKU100 cells,Confirmatory,20541293.0,
1375,511836,4,3,,103184924,3213,Active,,,4.5,IC50,Cytotoxicity against human KKU-M139 cells,Confirmatory,20541293.0,
1376,511837,4,3,,103184924,3213,Active,,,9.34,IC50,Cytotoxicity against human KKU-M156 cells,Confirmatory,20541293.0,
1377,511838,4,3,,103184924,3213,Active,,,1.62,IC50,Cytotoxicity against human KKU-M213 cells,Confirmatory,20541293.0,
1378,511839,4,3,,103184924,3213,Active,,,1.01,IC50,Cytotoxicity against human KKU-M214 cells,Confirmatory,20541293.0,
1379,521220,3,3,,103184924,3213,Active,,,,,Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay,Other,17417631.0,
1380,524790,7,2,,103184924,3213,Active,,,0.00056,IC50,Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1381,524791,7,2,,103184924,3213,Active,,,0.00093,IC50,Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1382,524792,7,2,,103184924,3213,Active,,,0.0017800000000000001,IC50,Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1383,524793,7,2,,103184924,3213,Active,,,0.00141,IC50,Antiplasmodial activity against Plasmodium falciparum Dd2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1384,524794,7,1,,103184924,3213,Active,,,0.0004,IC50,Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1385,524795,7,2,,103184924,3213,Active,,,0.0016600000000000002,IC50,Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1386,524796,7,1,,103184924,3213,Active,,,0.0005200000000000001,IC50,Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay,Confirmatory,19734910.0,
1387,540253,1,1,,56424143,3213,Inconclusive,5031833.0,10073.0,11.2202,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1388,540253,1,1,,56424143,3213,Inconclusive,5453555.0,5901.0,11.2202,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1389,540253,1,1,,56424143,3213,Inconclusive,19923142.0,3837.0,11.2202,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1390,540256,1,2,,855686,3213,Inconclusive,,,20.5962,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1391,540256,1,2,,50104008,3213,Inconclusive,,,25.1189,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1392,540256,1,2,,90341166,3213,Active,,,6.5104,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1393,540263,1,1,,56424143,3213,Inconclusive,5031833.0,10073.0,70.7946,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1394,540263,1,1,,56424143,3213,Inconclusive,19923142.0,3837.0,70.7946,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1395,540267,1,1,,56424143,3213,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
1396,540275,1,1,,855686,3213,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
1397,540276,1,2,,855686,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1398,540276,1,2,,11111146,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1399,540276,1,2,,11111147,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1400,540276,1,2,,50100236,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1401,540276,1,2,,50104008,3213,Active,420597.0,,4.4668,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1402,540276,1,2,,50104009,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1403,540276,1,2,,50104010,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1404,540276,1,2,,56424143,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1405,540276,1,2,,85231031,3213,Active,420597.0,,4.1095,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1406,540276,1,2,,90341166,3213,Inconclusive,420597.0,,9.1962,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1407,540277,1,1,,855686,3213,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
1408,540295,1,1,,56424143,3213,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
1409,540299,1,2,,92125514,3213,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
1410,540303,1,1,,56424143,3213,Active,6679377.0,18792.0,0.8913,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1411,540303,1,1,,56424143,3213,Active,7242179.0,18793.0,0.8913,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1412,540303,1,1,,56424143,3213,Active,257471003.0,18815.0,0.8913,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1413,540308,1,1,,56424143,3213,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
1414,540317,1,1,,56424143,3213,Inactive,187960037.0,10951.0,50.1187,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1415,540336,1,1,,56424143,3213,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1416,540336,1,1,,56424143,3213,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1417,540364,1,2,,56424143,3213,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
1418,548271,2,4,,103184924,3213,Unspecified,,,,,Antiviral activity against Ebolavirus infected in african green monkey COS1 cells assessed as inhibition of viral replication after 32 hrs by luciferase reporter gene assay,Other,20421407.0,
1419,548272,2,4,,103184924,3213,Unspecified,,,,,Cytotoxicity against african green monkey COS1 cells assessed as reduction in cell viability after 32 hrs by luminescent assay,Other,20421407.0,
1420,551260,4,2,,103184924,3213,Active,,,1.9,IC50,Cytotoxicity against human A549 cells,Confirmatory,21095131.0,
1421,551263,2,7,,103184924,3213,Inconclusive,,,,,Inhibition of topoisomerase 1,Other,21095131.0,
1422,551264,4,2,,103184924,3213,Active,,,2.3,IC50,Cytotoxicity against human Col2 cells,Confirmatory,21095131.0,
1423,551265,4,3,,103184924,3213,Active,,,2.2,IC50,Cytotoxicity against human SNU638 cells,Confirmatory,21095131.0,
1424,551266,4,2,,103184924,3213,Active,,,5.8,IC50,Cytotoxicity against human HL60 cells,Confirmatory,21095131.0,
1425,551267,4,2,,103184924,3213,Active,,,4.3,IC50,Cytotoxicity against human HT1080 cells,Confirmatory,21095131.0,
1426,576613,4,2,,103184924,3213,Active,,,0.64,IC50,Growth inhibition in human HL60 cells after 72 hrs by trypan blue assay,Confirmatory,21216603.0,
1427,576614,4,2,,103184924,3213,Active,,,0.47,IC50,Growth inhibition in human A431 cells after 72 hrs by trypan blue assay,Confirmatory,21216603.0,
1428,576615,4,2,,103184924,3213,Active,,,0.31,IC50,Growth inhibition in human HeLa cells after 72 hrs by trypan blue assay,Confirmatory,21216603.0,
1429,578678,4,2,,103184924,3213,Active,,,1.9,IC50,Cytotoxicity against human A549 cells by MTT assay,Confirmatory,21353568.0,
1430,578679,4,2,,103184924,3213,Active,,,2.3,IC50,Cytotoxicity against human Col2 cells by MTT assay,Confirmatory,21353568.0,
1431,578680,4,2,,103184924,3213,Active,,,5.8,IC50,Cytotoxicity against human HL60 cells by MTT assay,Confirmatory,21353568.0,
1432,578681,4,2,,103184924,3213,Active,,,4.3,IC50,Cytotoxicity against human HT1080 cells by MTT assay,Confirmatory,21353568.0,
1433,578684,4,3,,103184924,3213,Active,,,2.2,IC50,Cytotoxicity against human SNU638 cells by MTT assay,Confirmatory,21353568.0,
1434,587892,4,2,,103184924,3213,Active,,,1.79,IC50,Cytotoxicity against human KB cells by resazurin microplate assay,Confirmatory,21302964.0,
1435,587893,4,3,,103184924,3213,Active,,,2.76,IC50,Cytotoxicity against human NCI-H187 by resazurin microplate assay,Confirmatory,21302964.0,
1436,587894,4,2,,103184924,3213,Active,,,3.82,IC50,Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay,Confirmatory,21302964.0,
1437,588334,1,1,,56424143,3213,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
1438,588335,1,1,,56424143,3213,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
1439,588342,1,1,,855686,3213,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
1440,588345,1,1,,56424143,3213,Active,6978787.0,25255.0,0.231,AC50_uM,MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1441,588348,1,1,,56424143,3213,Inactive,,,,AC50_uM,MLPCN Dyrk1A Artifact Assay Measured in Biochemical System Using Plate Reader - 2124-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
1442,588349,1,1,,90341166,3213,Inactive,,,,Potency,qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay,Confirmatory,,
1443,588352,1,2,,56424143,3213,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
1444,588354,1,1,,56424143,3213,Active,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
1445,588358,1,2,,56424143,3213,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
1446,588368,1,2,,855686,3213,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies from validation set,Screening,,
1447,588378,1,1,,90341166,3213,Inconclusive,171543895.0,6311.0,10.0,Potency,qHTS for Inhibitors of ATXN expression: Validation,Confirmatory,,
1448,588391,1,1,,56424143,3213,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1449,588405,1,1,,56424143,3213,Active,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
1450,588413,1,2,,56424143,3213,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
1451,588436,1,1,,56424143,3213,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
1452,588453,1,1,,56424143,3213,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1453,588453,1,1,,85231031,3213,Inconclusive,8659577.0,58819.0,25.1189,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1454,588453,1,1,,90341166,3213,Inconclusive,8659577.0,58819.0,23.7781,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1455,588456,1,1,,56424143,3213,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1456,588456,1,1,,90341166,3213,Inactive,8659577.0,58819.0,3.5481,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
1457,588458,1,1,,56424143,3213,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
1458,588459,1,2,,855686,3213,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,16604538.0,
1459,588459,1,2,,855686,3213,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20035615.0,
1460,588459,1,2,,855686,3213,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20938917.0,
1461,588460,1,2,,855686,3213,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,16604538.0,
1462,588460,1,2,,855686,3213,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20035615.0,
1463,588460,1,2,,855686,3213,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20938917.0,
1464,588461,1,2,,855686,3213,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,16604538.0,
1465,588461,1,2,,855686,3213,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20035615.0,
1466,588461,1,2,,855686,3213,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20938917.0,
1467,588473,1,1,,56424143,3213,Active,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1468,588473,1,1,,56424143,3213,Active,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1469,588475,1,2,,56424143,3213,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1470,588475,1,2,,56424143,3213,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
1471,588478,1,2,,124799446,3213,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
1472,588489,1,1,,56424143,3213,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
1473,588492,1,1,,56424143,3213,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
1474,588493,1,2,,56424143,3213,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
1475,588497,1,2,,56424143,3213,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
1476,588497,1,2,,56424143,3213,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
1477,588497,1,2,,56424143,3213,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
1478,588499,1,3,,56424143,3213,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
1479,588499,1,3,,56424143,3213,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
1480,588499,1,3,,56424143,3213,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
1481,588501,1,2,,56424143,3213,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
1482,588501,1,2,,56424143,3213,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
1483,588501,1,2,,56424143,3213,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
1484,588506,1,2,,855686,3213,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors with Validation compound Set,Screening,,
1485,588511,1,2,,855686,3213,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
1486,588517,1,2,,855686,3213,Inactive,,,,,Compound fluorescence counter screen for HTS for inhibitors of efflux pump with Cherry Pick1 compound set,Screening,,
1487,588517,1,2,,56424143,3213,Inactive,,,,,Compound fluorescence counter screen for HTS for inhibitors of efflux pump with Cherry Pick1 compound set,Screening,,
1488,588518,1,3,,855686,3213,Inactive,,,,,"Flow Cytometric HTS singleplex for inhibitors of yeast efflux pump, specifically Mdr1 with Cherry Pick1 compound set",Screening,,
1489,588518,1,3,,56424143,3213,Inactive,,,,,"Flow Cytometric HTS singleplex for inhibitors of yeast efflux pump, specifically Mdr1 with Cherry Pick1 compound set",Screening,,
1490,588519,1,2,,92125514,3213,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
1491,588520,1,3,,855686,3213,Inactive,93115982.0,,,,"Flow Cytometric HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr2 with Cherry Pick1 compound set",Screening,,
1492,588520,1,3,,56424143,3213,Inactive,93115982.0,,,,"Flow Cytometric HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr2 with Cherry Pick1 compound set",Screening,,
1493,588522,1,3,,855686,3213,Inactive,93115976.0,,,,"Flow Cytometric HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr1 with Cherry Pick1 compound set",Screening,,
1494,588522,1,3,,56424143,3213,Inactive,93115976.0,,,,"Flow Cytometric HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr1 with Cherry Pick1 compound set",Screening,,
1495,588549,1,1,,56424143,3213,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1496,588550,1,1,,855686,3213,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for Validation Compound Set,Screening,,
1497,588579,1,1,,11111147,3213,Inconclusive,7705344.0,51426.0,2.6679,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1498,588579,1,1,,56424143,3213,Inconclusive,7705344.0,51426.0,79.4328,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1499,588579,1,1,,90341166,3213,Inconclusive,7705344.0,51426.0,37.6858,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
1500,588590,1,1,,50104008,3213,Active,154350220.0,11201.0,14.1254,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1501,588590,1,1,,56424143,3213,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
1502,588591,1,1,,50104008,3213,Inconclusive,5729982.0,5429.0,25.1189,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1503,588591,1,1,,56424143,3213,Inconclusive,5729982.0,5429.0,89.1251,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
1504,588604,1,2,,855686,3213,Inactive,93115982.0,,,EC50_MICROM,"Dose Response HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr2 with Hit compounds from Cherry Pick1",Confirmatory,,
1505,588604,1,2,,56424143,3213,Inactive,93115982.0,,,EC50_MICROM,"Dose Response HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr2 with Hit compounds from Cherry Pick1",Confirmatory,,
1506,588606,1,2,,855686,3213,Inactive,93115976.0,,,EC50_MICROM,"Dose Response HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr1 with Hit compounds from Cherry Pick1",Confirmatory,,
1507,588606,1,2,,56424143,3213,Inactive,93115976.0,,,EC50_MICROM,"Dose Response HTS singleplex for inhibitors of yeast efflux pump, specifically Cdr1 with Hit compounds from Cherry Pick1",Confirmatory,,
1508,588608,1,2,,855686,3213,Inactive,,,,EC50_MICROM,"Dose Response HTS singleplex for inhibitors of yeast efflux pump, specifically Mdr1 with Hit compounds from Cherry Pick1",Confirmatory,,
1509,588608,1,2,,56424143,3213,Inactive,,,,EC50_MICROM,"Dose Response HTS singleplex for inhibitors of yeast efflux pump, specifically Mdr1 with Hit compounds from Cherry Pick1",Confirmatory,,
1510,588620,1,2,,855686,3213,Inactive,,,,EC50_MICROM,Dose response compound fluorescence counter screen for HTS for inhibitors of efflux pump with Hit compounds from Cherry Pick1,Confirmatory,,
1511,588620,1,2,,56424143,3213,Inactive,,,,EC50_MICROM,Dose response compound fluorescence counter screen for HTS for inhibitors of efflux pump with Hit compounds from Cherry Pick1,Confirmatory,,
1512,588621,1,1,,56424143,3213,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
1513,588627,1,1,,855686,3213,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
1514,588664,1,2,,56424143,3213,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1515,588664,1,2,,56424143,3213,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
1516,588674,1,2,,56424143,3213,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1517,588675,1,1,,855686,3213,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
1518,588676,1,1,,855686,3213,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
1519,588685,1,1,,855686,3213,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with Validation compound set,Screening,,
1520,588689,1,1,,56424143,3213,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
1521,588692,2,1,,56424143,3213,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1522,588726,1,2,,56424143,3213,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
1523,588727,1,1,,56424143,3213,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
1524,588792,1,1,,56424143,3213,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
1525,588794,1,1,,56424143,3213,Active,9629429.0,,,,Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16),Screening,,
1526,588795,1,1,,56424143,3213,Inconclusive,4758356.0,2237.0,3.9811,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1527,588795,1,1,,90341166,3213,Active,4758356.0,2237.0,11.9173,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
1528,588814,1,3,,56424143,3213,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
1529,588819,1,4,,56424143,3213,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
1530,588820,1,1,,56424143,3213,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1).,Screening,,
1531,588824,1,1,,56424143,3213,Active,9629429.0,,,,Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16).,Screening,,
1532,588834,2,1,,50104008,3213,Active,325651834.0,3757.0,19.9526,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
1533,588850,1,1,,56424143,3213,Active,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
1534,588852,1,3,,56424143,3213,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
1535,588855,1,1,,56424143,3213,Inconclusive,18418623.0,4088.0,35.4813,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
1536,588856,1,1,,56424143,3213,Active,,,12.5893,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
1537,589992,3,2,,103184924,3213,Active,,,0.21,IC50,Cytotoxicity against human HT1080 cells after 6 days by SRB assay,Confirmatory,21330015.0,
1538,589993,3,2,,103184924,3213,Active,,,0.38,IC50,Cytotoxicity against human K562 cells after 6 days by SRB assay,Confirmatory,21330015.0,
1539,589996,3,2,,103184924,3213,Active,,,0.47,IC50,Cytotoxicity against human A549 cells after 6 days by SRB assay,Confirmatory,21330015.0,
1540,589997,3,2,,103184924,3213,Active,,,0.41,IC50,Cytotoxicity against human HCT116 cells after 6 days by SRB assay,Confirmatory,21330015.0,
1541,589999,3,3,,103184924,3213,Active,,,1.64,IC50,Cytotoxicity against human SNU638 cells after 6 days by SRB assay,Confirmatory,21330015.0,
1542,593903,3,2,,103184924,3213,Active,,,1.6,IC50,Antitumor activity against human MCF7 cells after 72 hrs by MTT assay,Confirmatory,21458275.0,
1543,593904,3,2,,103184924,3213,Active,,,3.4,IC50,Antitumor activity against human A549 cells after 72 hrs by MTT assay,Confirmatory,21458275.0,
1544,593905,3,2,,103184924,3213,Unspecified,,,10.0,IC50,Antitumor activity against human NHDF cells after 72 hrs by MTT assay,Confirmatory,21458275.0,
1545,595429,4,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU100 cells by sulforhodamine B assay,Other,21341709.0,
1546,595430,4,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M139 cells by sulforhodamine B assay,Other,21341709.0,
1547,595431,4,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M156 cells by sulforhodamine B assay,Other,21341709.0,
1548,595432,4,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M213 cells by sulforhodamine B assay,Other,21341709.0,
1549,595433,4,3,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KKU-M214 cells by sulforhodamine B assay,Other,21341709.0,
1550,595434,4,2,,103184924,3213,Unspecified,,,,,Cytotoxicity against human KB cells by sulforhodamine B assay,Other,21341709.0,
1551,595895,3,2,,103184924,3213,Active,,,12.0,IC50,Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay,Confirmatory,21473608.0,
1552,602123,1,1,,56424143,3213,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
1553,602141,1,1,,56424143,3213,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
1554,602162,1,1,,56424143,3213,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
1555,602163,1,1,,56424143,3213,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
1556,602179,1,2,,56424143,3213,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
1557,602229,1,1,,56424143,3213,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
1558,602233,1,1,,56424143,3213,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
1559,602244,1,2,,56424143,3213,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
1560,602247,1,2,,56424143,3213,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1561,602248,1,2,,56424143,3213,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
1562,602250,1,2,,56424143,3213,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
1563,602252,1,1,,56424143,3213,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1564,602252,1,1,,56424143,3213,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1565,602261,1,1,,56424143,3213,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
1566,602274,1,2,,56424143,3213,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
1567,602276,1,1,,855686,3213,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-SeV Stimulus,Screening,,
1568,602277,1,1,,855686,3213,Active,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus,Screening,,
1569,602281,1,1,,56424143,3213,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1570,602281,1,1,,56424143,3213,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1571,602310,1,2,,56424143,3213,Inconclusive,13399304.0,60489.0,15.8489,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
1572,602313,1,1,,56424143,3213,Active,22907044.0,200316.0,10.0,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
1573,602314,1,2,,92125514,3213,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
1574,602329,1,1,,56424143,3213,Active,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1575,602332,1,1,,11111147,3213,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1576,602332,1,1,,56424143,3213,Inconclusive,168984549.0,,44.6684,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1577,602332,1,1,,90341166,3213,Inconclusive,168984549.0,,26.1216,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
1578,602340,1,2,,56424143,3213,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
1579,602342,2,1,,56424143,3213,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1580,602346,1,1,,56424143,3213,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1581,602363,1,1,,56424143,3213,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
1582,602393,1,1,,56424143,3213,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1583,602396,1,2,,56424143,3213,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
1584,602399,1,2,,56424143,3213,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
1585,602405,1,1,,56424143,3213,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1586,602410,1,1,,56424143,3213,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
1587,602429,1,1,,56424143,3213,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
1588,602438,1,1,,56424143,3213,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
1589,602440,1,1,,56424143,3213,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
1590,602449,1,2,,56424143,3213,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
1591,602481,1,1,,56424143,3213,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1592,613241,3,3,,103184924,3213,Active,,,2.77,IC50,Cytotoxicity against human NCI-H187 cells after 5 days by resazurin microplate assay,Confirmatory,21641693.0,
1593,613242,3,2,,103184924,3213,Active,,,1.78,IC50,Cytotoxicity against human KB cells after 3 days by resazurin microplate assay,Confirmatory,21641693.0,
1594,613243,3,2,,103184924,3213,Active,,,3.82,IC50,Cytotoxicity against african green monkey Vero cells expressing green fluorescent protein after 4 days by fluorescence analysis,Confirmatory,21641693.0,
1595,623870,1,1,,56424143,3213,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1596,623870,1,1,,56424143,3213,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1597,623877,1,1,,56424143,3213,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
1598,623901,1,1,,56424143,3213,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
1599,624037,1,3,,56424143,3213,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1600,624038,1,3,,56424143,3213,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1601,624040,1,3,,56424143,3213,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
1602,624125,1,4,,56424143,3213,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1603,624126,1,3,,56424143,3213,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1604,624127,1,2,,56424143,3213,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
1605,624146,1,1,,90341166,3213,Inconclusive,71051501.0,2744.0,22.3872,Potency,qHTS for Inhibitors of Glutaminase (GLS): LOPAC Validation,Confirmatory,,
1606,624147,1,1,,90341166,3213,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors: LOPAC Validation,Confirmatory,,
1607,624148,1,2,,90341166,3213,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists: LOPAC Validation,Confirmatory,,
1608,624149,1,1,,90341166,3213,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators: LOPAC Validation,Confirmatory,,
1609,624156,1,1,,85787856,3213,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
1610,624168,1,1,,56424143,3213,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
1611,624169,1,1,,56424143,3213,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
1612,624170,1,1,,56424143,3213,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
1613,624171,1,1,,56424143,3213,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
1614,624172,1,1,,56424143,3213,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
1615,624173,1,3,,56424143,3213,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
1616,624178,1,1,,56424143,3213,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
1617,624202,1,1,,56424143,3213,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
1618,624204,1,2,,56424143,3213,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
1619,624246,1,1,,56424143,3213,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
1620,624256,1,2,,56424143,3213,Inconclusive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
1621,624263,1,1,,56424143,3213,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1622,624263,1,1,,56424143,3213,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
1623,624267,1,2,,56424143,3213,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1624,624267,1,2,,56424143,3213,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
1625,624268,1,3,,56424143,3213,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
1626,624288,1,1,,56424143,3213,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
1627,624296,1,1,,855686,3213,Active,7705682.0,51053.0,5.8048,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1628,624296,1,1,,56424143,3213,Inconclusive,7705682.0,51053.0,9.2,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
1629,624297,1,1,,855686,3213,Active,7705682.0,51053.0,7.3078,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1630,624297,1,1,,56424143,3213,Inconclusive,7705682.0,51053.0,14.1254,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
1631,624304,1,2,,56424143,3213,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
1632,624330,1,2,,56424143,3213,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
1633,624349,1,2,,92125514,3213,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1634,624349,1,2,,121363185,3213,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
1635,624352,1,1,,56424143,3213,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
1636,624354,1,1,,56424143,3213,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
1637,624414,1,1,,56424143,3213,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1638,624415,1,2,,56424143,3213,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
1639,624417,1,1,,56424143,3213,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
1640,624418,1,1,,56424143,3213,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
1641,624455,1,1,,90341166,3213,Inactive,299681.0,1812.0,0.0041,Potency,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Hit Validation in HTRF,Confirmatory,,
1642,624463,1,1,,56424143,3213,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
1643,624464,1,1,,56424143,3213,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
1644,624465,1,1,,56424143,3213,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
1645,624483,1,1,,56424143,3213,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1646,627039,5,1,,103184924,3213,Active,,,1.1,IC50,Antiproliferative activity against human A549 cells after 3 days by SRB assay,Confirmatory,21916433.0,
1647,627040,5,1,,103184924,3213,Active,,,1.0,IC50,Antiproliferative activity against human NCI-H292 cells after 3 days by SRB assay,Confirmatory,21916433.0,
1648,627041,5,1,,103184924,3213,Active,,,0.2,IC50,Antiproliferative activity against human SK-MES cells after 3 days by SRB assay,Confirmatory,21916433.0,
1649,627042,5,1,,103184924,3213,Active,,,0.2,IC50,Antiproliferative activity against human NCI-H1993 cells after 3 days by SRB assay,Confirmatory,21916433.0,
1650,627043,3,3,,103184924,3213,Active,,,0.6,IC50,Antiproliferative activity against human H1299 cells after 3 days by SRB assay,Confirmatory,21916433.0,
1651,627044,3,2,,103184924,3213,Active,,,0.8,IC50,Antiproliferative activity against human NCI-H358 cells after 3 days by SRB assay,Confirmatory,21916433.0,
1652,627045,5,1,,103184924,3213,Inconclusive,,,,IC50,Antiproliferative activity against gefitinib resistant human NCI-H292 cells after 3 days by SRB assay,Confirmatory,21916433.0,
1653,627046,5,1,,103184924,3213,Inconclusive,,,,IC50,Antiproliferative activity against gefitinib resistant human NCI-H1993 cells after 3 days by SRB assay,Confirmatory,21916433.0,
1654,629417,3,2,,103184924,3213,Active,,,2.9,GI50,Growth inhibition of human HepG2 cells after 72 hrs by SRB assay,Confirmatory,22014996.0,
1655,629418,3,3,,103184924,3213,Active,,,3.3,GI50,Growth inhibition of porcine primary hepatocytes after 72 hrs by SRB assay,Confirmatory,22014996.0,
1656,636830,3,2,,103184924,3213,Active,,,9.8,IC50,Cytotoxicity against african green monkey Vero cells by green fluorescent protein microplate assay,Confirmatory,21995505.0,
1657,637866,2,1,,103184924,3213,Active,,,2.44,ED50,Cytotoxicity against mouse P388 cells by SRB assay,Confirmatory,22154665.0,
1658,637867,2,1,,103184924,3213,Active,,,2.46,ED50,Cytotoxicity against human KB cells by SRB assay,Confirmatory,22154665.0,
1659,637868,2,1,,103184924,3213,Active,,,2.72,ED50,Cytotoxicity against human Col2 cells by SRB assay,Confirmatory,22154665.0,
1660,637869,2,1,,103184924,3213,Active,,,2.71,ED50,Cytotoxicity against human MCF7 cells by SRB assay,Confirmatory,22154665.0,
1661,637870,2,1,,103184924,3213,Active,,,1.62,ED50,Cytotoxicity against human Lu1 cells by SRB assay,Confirmatory,22154665.0,
1662,637871,2,1,,103184924,3213,Active,,,3.56,ED50,Cytotoxicity against rat ASK cells by SRB assay,Confirmatory,22154665.0,
1663,641622,3,3,,103184924,3213,Active,,,1.82,IC50,Cytotoxicity against human NCI-H187 cells by SRB assay,Confirmatory,22004007.0,
1664,641785,3,2,,103184924,3213,Active,,,1.25,IC50,Cytotoxicity against human KB cells by SRB assay,Confirmatory,22004007.0,
1665,651550,1,1,,56424143,3213,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1666,651560,1,1,,56424143,3213,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1667,651582,1,1,,56424143,3213,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
1668,651635,1,3,,11111147,3213,Inconclusive,171543895.0,6311.0,3.5481,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1669,651635,1,3,,56424143,3213,Inconclusive,171543895.0,6311.0,10.0,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1670,651635,1,3,,90341166,3213,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1671,651636,1,1,,56424143,3213,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1672,651644,1,1,,56424143,3213,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1673,651647,1,1,,56424143,3213,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1674,651654,1,1,,56424143,3213,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1675,651660,1,1,,56424143,3213,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors             Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1676,651699,1,1,,56424143,3213,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1677,651699,1,1,,56424143,3213,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1678,651702,1,2,,56424143,3213,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1679,651704,2,1,,56424143,3213,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1680,651724,1,1,,56424143,3213,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1681,651725,1,1,,56424143,3213,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1682,651768,1,2,,56424143,3213,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1683,651812,1,1,,56424143,3213,Active,13399304.0,60489.0,14.581,Potency,qHTS for inhibitors of Vif-A3G interactions: Cherry picks,Confirmatory,,
1684,651813,1,1,,56424143,3213,Inconclusive,13399304.0,60489.0,29.0929,Potency,qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen,Confirmatory,,
1685,651814,1,1,,56424143,3213,Inconclusive,22907044.0,200316.0,18.3564,Potency,qHTS for inhibitors of Vif-A3F interactions: Cherry picks,Confirmatory,,
1686,651815,1,1,,56424143,3213,Inconclusive,22907044.0,200316.0,29.0929,Potency,qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen,Confirmatory,,
1687,651819,1,1,,56424143,3213,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1688,651820,1,1,,855686,3213,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1689,651820,1,1,,56424143,3213,Inconclusive,,,2.2387,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1690,651828,1,2,,121361347,3213,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
1691,651965,1,1,,56424143,3213,Inconclusive,2668494.0,,17.7828,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1692,651999,1,1,,56424143,3213,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1693,652025,1,1,,56424143,3213,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1694,652048,1,2,,56424143,3213,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1695,652051,1,1,,56424143,3213,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1696,652054,1,1,,56424143,3213,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1697,652104,1,1,,56424143,3213,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1698,652105,1,1,,56424143,3213,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1699,652106,1,1,,56424143,3213,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1700,652106,1,1,,90341166,3213,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1701,652163,1,1,,56424143,3213,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1702,664537,2,2,,103184924,3213,Active,,,5.2,IC50,Cytotoxicity against human KB cells by resazurin reduction assay,Confirmatory,22482432.0,
1703,664539,2,3,,103184924,3213,Active,,,3.1,IC50,Cytotoxicity against human NCI-H187 cells by resazurin reduction assay,Confirmatory,22482432.0,
1704,686970,1,2,,56424143,3213,Active,49168486.0,3417.0,10.3225,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1705,686971,1,2,,56424143,3213,Active,,,3.6626,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1706,686977,2,1,,49698585,3213,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1707,686978,1,1,,56424143,3213,Active,79154014.0,55775.0,1.4581,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1708,686979,1,1,,56424143,3213,Active,79154014.0,55775.0,2.3109,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1709,687035,1,1,,163564485,3213,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening assay of LOPAC1280 to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
1710,687037,1,3,,163564485,3213,Inactive,,,,,Fluorescence-based counterscreen assay of HCV NS3 helicase-DNA binding inhibitors in LOPAC1280: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-DNA-NS3h complex,Screening,,
1711,695925,2,2,,103184924,3213,Unspecified,,,182.0,IC50,Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay,Confirmatory,22695131.0,
1712,697852,1,7,,103184924,3213,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1713,697853,1,7,,103184924,3213,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1714,720504,1,1,,56424143,3213,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1715,720532,1,1,,11111147,3213,Active,420597.0,,4.4668,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1716,720533,1,1,,11111147,3213,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1717,720538,1,2,,90341166,3213,Inactive,220983390.0,410.0,22.3872,Potency,qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay,Confirmatory,,
1718,720542,1,2,,56424143,3213,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1719,720551,1,2,,56424143,3213,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1720,720553,1,2,,56424143,3213,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1721,720559,1,2,,90341166,3213,Inactive,112927.0,351.0,,Potency,qHTS for compounds that reverse cellular toxicity of Amyloid beta (A-beta) peptide in yeast: LOPAC Validation Assay,Confirmatory,,
1722,720572,1,2,,90341166,3213,Inactive,3063388.0,5071.0,,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (NLuc Reporter),Confirmatory,,
1723,720573,1,2,,90341166,3213,Inactive,3063388.0,5071.0,29.0929,Potency,qHTS for Activators of Parkin Expression:  LOPAC Validation Assay (FLuc Reporter),Confirmatory,,
1724,720579,2,1,,56424143,3213,Active,222762.0,3707576.0,11.2202,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1725,720580,1,1,,56424143,3213,Active,222762.0,3707576.0,10.0,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1726,720707,1,2,,56424143,3213,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1727,720708,1,2,,56424143,3213,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1728,720709,1,2,,56424143,3213,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1729,720711,1,2,,56424143,3213,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1730,720717,1,3,,92125514,3213,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1731,735335,2,1,,103184924,3213,Active,,,2.2,ED50,Cytotoxicity against rat ASK cells after 72 hrs by sulforhodamine B assay,Confirmatory,23550966.0,
1732,735336,2,1,,103184924,3213,Active,,,1.9,ED50,Cytotoxicity against human HEK293 cells after 72 hrs by sulforhodamine B assay,Confirmatory,23550966.0,
1733,735337,2,1,,103184924,3213,Active,,,1.1,ED50,Cytotoxicity against human Lu1 cells after 72 hrs by sulforhodamine B assay,Confirmatory,23550966.0,
1734,735338,2,1,,103184924,3213,Active,,,2.3,ED50,Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B assay,Confirmatory,23550966.0,
1735,735339,2,2,,103184924,3213,Active,,,2.2,ED50,Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B assay,Confirmatory,23550966.0,
1736,735340,2,1,,103184924,3213,Active,,,2.2,ED50,Cytotoxicity against human Col2 cells after 72 hrs by sulforhodamine B assay,Confirmatory,23550966.0,
1737,735341,2,1,,103184924,3213,Active,,,1.9,ED50,Cytotoxicity against mouse P388 cells after 48 hrs by sulforhodamine B assay,Confirmatory,23550966.0,
1738,735342,1,4,,103184924,3213,Active,,,4.87,IC50,Cytotoxicity against human KB cells by resazurin assay,Confirmatory,23806072.0,
1739,743205,1,1,,90341166,3213,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1740,743205,1,1,,90341166,3213,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: Diaphorase-coupled assay,Confirmatory,,
1741,743206,1,1,,90341166,3213,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1742,743206,1,1,,90341166,3213,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: ADP-Glo assay,Confirmatory,,
1743,743207,1,1,,90341166,3213,Inactive,4503951.0,2645.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1744,743207,1,1,,90341166,3213,Inactive,221625433.0,2646.0,,Potency,qHTS assay for inhibitors of recombinant human GCK-GKRP interaction: HTRF assay,Confirmatory,,
1745,743244,1,1,,90341166,3213,Active,,,1.7783,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
1746,743247,1,2,,56424143,3213,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1747,743255,1,1,,56424143,3213,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1748,743266,1,2,,56424143,3213,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1749,743279,1,2,,56424143,3213,Active,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1750,743398,1,1,,56424143,3213,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1751,748997,1,1,,103184924,3213,Inconclusive,,,,,Inhibition of TEM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins relative to control,Other,23591260.0,
1752,748998,1,1,,103184924,3213,Unspecified,,,30.0,IC50,Inhibition of TEM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins,Confirmatory,23591260.0,
1753,748999,1,1,,103184924,3213,Inconclusive,,,,,Inhibition of NDM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins relative to control,Other,23591260.0,
1754,749000,1,1,,103184924,3213,Unspecified,,,30.0,IC50,Inhibition of NDM-1 (unknown origin) using nitrocefin as substrate preincubated 10 mins followed by substrate addition measured after 20 mins,Confirmatory,23591260.0,
1755,761772,1,1,,103184924,3213,Active,,,1.16,IC50,Cytotoxicity against human NCI-H187 cells by SRB assay,Confirmatory,23806014.0,
1756,761773,1,1,,103184924,3213,Active,,,1.19,IC50,Cytotoxicity against african green monkey Vero cells by SRB assay,Confirmatory,23806014.0,
1757,761775,1,3,,103184924,3213,Active,,,1.19,IC50,Cytotoxicity against human KB cells by SRB assay,Confirmatory,23806014.0,
1758,776751,1,1,,103184924,3213,Active,,,2.06,GI50,Growth inhibition of PLP2 cells after 48 hrs by SRB assay,Confirmatory,24121236.0,
1759,776752,1,1,,103184924,3213,Active,,,1.91,GI50,Growth inhibition of human HCT15 cells after 48 hrs by SRB assay,Confirmatory,24121236.0,
1760,776753,1,1,,103184924,3213,Active,,,3.28,GI50,Growth inhibition of human HeLa cells after 48 hrs by SRB assay,Confirmatory,24121236.0,
1761,776754,1,1,,103184924,3213,Active,,,5.77,GI50,Growth inhibition of human NCI-H460 cells after 48 hrs by SRB assay,Confirmatory,24121236.0,
1762,776756,1,1,,103184924,3213,Active,,,4.32,GI50,Growth inhibition of human MCF7 cells after 48 hrs by SRB assay,Confirmatory,24121236.0,
1763,776757,1,1,,103184924,3213,Active,,,5.38,GI50,Growth inhibition of human HepG2 cells after 48 hrs by SRB assay,Confirmatory,24121236.0,
1764,1053175,2,1,,178126464,3213,Active,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
1765,1053188,2,1,,56424143,3213,Inactive,,,,,Primary Screen Inhibitors of CD40 Signaling in BL2 Cells Measured in Cell-Based System Using Plate Reader - 7124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1766,1053190,1,1,,188376278,3213,Active,53832009.0,8912.0,,,Confirmed inhibitors of the Cav3 T-type Calcium Channel,Other,,
1767,1077394,1,2,,103184924,3213,Active,,,16.72,IC50,Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay,Confirmatory,,
1768,1077395,1,2,,103184924,3213,Active,,,9.81,IC50,Cytotoxicity against human HeLa cells after 48 hrs by MTT assay,Confirmatory,,
1769,1125058,1,1,,103184924,3213,Active,,,0.3,GI50,Growth inhibition of human HeLa cells after 72 hrs by trypan blue assay,Confirmatory,24631729.0,
1770,1125059,1,1,,103184924,3213,Active,,,2.0,GI50,Growth inhibition of human HL60 cells after 72 hrs by trypan blue assay,Confirmatory,24631729.0,
1771,1125060,1,1,,103184924,3213,Active,,,3.2,GI50,Growth inhibition of human A431 cells after 72 hrs by trypan blue assay,Confirmatory,24631729.0,
1772,1140784,1,2,,103184924,3213,Active,,,0.00126,IC50,Cytotoxicity against human KB cells assessed as inhibition of cell growth after 3 days by MTT assay,Confirmatory,24745968.0,
1773,1140785,1,1,,103184924,3213,Active,,,0.00126,IC50,Cytotoxicity against human HepG2 cells assessed as inhibition of cell growth after 3 days by MTT assay,Confirmatory,24745968.0,
1774,1140786,1,1,,103184924,3213,Active,,,0.00182,IC50,Cytotoxicity against human Lu cells assessed as inhibition of cell growth after 3 days by MTT assay,Confirmatory,24745968.0,
1775,1140787,1,1,,103184924,3213,Active,,,0.00215,IC50,Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 3 days by MTT assay,Confirmatory,24745968.0,
1776,1143516,3,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human HuCCa1 cells after 48 hrs by MTT assay,Confirmatory,24836071.0,
1777,1143517,3,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay,Confirmatory,24836071.0,
1778,1143518,3,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,Confirmatory,24836071.0,
1779,1143519,3,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human MOLT3 cells after 48 hrs by MTT assay,Confirmatory,24836071.0,
1780,1143520,3,1,,103184924,3213,Active,,,1.94,IC50,Cytotoxicity against african green monkey Vero cells after 4 days by GFP detection method,Confirmatory,24836071.0,
1781,1152797,1,1,,103184924,3213,Unspecified,,,,,"Antimalarial activity against Plasmodium berghei infected in mouse assessed as suppression of parasitemia at 10 mg/kg, po by Peters 4 day suppressive test",Other,24813729.0,
1782,1152798,1,1,,103184924,3213,Active,,,,,"Antimalarial activity against Plasmodium berghei infected in mouse assessed as total elimination of parasitemia at 50 mg/kg, po after 5 to 7 days",Other,24813729.0,
1783,1152799,1,1,,103184924,3213,Unspecified,,,,,"Antimalarial activity against Plasmodium berghei infected in mouse assessed as mouse mean survival time at 50 mg/kg, po",Other,24813729.0,
1784,1152802,1,1,,103184924,3213,Active,,,1.13,IC50,Antiplasmodial activity against Plasmodium falciparum,Confirmatory,24813729.0,
1785,1152803,1,1,,103184924,3213,Active,,,0.81,IC50,Antiplasmodial activity against multi-drug resistant Plasmodium falciparum K1 in human erythrocytes assessed as growth inhibition after 48 hrs by optical microscopy,Confirmatory,24813729.0,
1786,1152804,1,1,,103184924,3213,Active,,,0.35,IC50,Antiplasmodial activity against drug susceptible Plasmodium falciparum 3D7 NF54 isolate in human erythrocytes assessed as growth inhibition after 48 hrs by optical microscopy,Confirmatory,24813729.0,
1787,1152806,1,1,,103184924,3213,Unspecified,,,140.0,IC50,Cytotoxicity against mouse macrophages after 18 hrs by MTT assay,Confirmatory,24813729.0,
1788,1152807,1,1,,103184924,3213,Unspecified,,,,,"Selectivity index, ratio of IC50 for mouse macrophages to IC50 for Plasmodium falciparum",Other,24813729.0,
1789,1154169,1,2,,103184924,3213,Active,,,2.25,IC50,Cytotoxicity against human KB cells assessed as growth inhibition by resazurin microplate assay,Confirmatory,24857542.0,
1790,1154170,1,1,,103184924,3213,Active,,,6.48,IC50,Cytotoxicity against african green monkey Vero cells by green fluorescent protein detection method,Confirmatory,24857542.0,
1791,1154171,1,1,,103184924,3213,Unspecified,,,,,"Selectivity index, ratio of IC50 for african green monkey Vero cells to IC50 for human KB cells",Other,24857542.0,
1792,1154293,1,1,,103184924,3213,Active,,,2.1,IC50,Cytotoxicity against human HeLaS3 cells assessed as cell viability after 24 to 72 hrs by MTT assay,Confirmatory,24863982.0,
1793,1159524,1,1,,56424143,3213,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1794,1159580,2,1,,268738148,3213,Active,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
1795,1159583,2,1,,178126464,3213,Active,,,,,High throughput screen for small molecule inhibitors of a hypoxia-regulated fluorescent biosensor in Mycobacterium tuberculosis,Other,,
1796,1159585,1,2,,307068478,3213,Inactive,124801388.0,812762.0,,CDPK1_IC50_uM,Biochemical screen of P. falciparum CDPK1,Confirmatory,26934697.0,
1797,1159586,1,2,,307068478,3213,Inactive,124513486.0,813740.0,,PK6_IC50_uM,Biochemical screen of P. falciparum PK6,Confirmatory,26934697.0,
1798,1159587,1,2,,307068478,3213,Inactive,124801229.0,812721.0,,PK7_IC50_uM,Biochemical screen of P. falciparum PK7,Confirmatory,26934697.0,
1799,1159588,1,2,,307068478,3213,Inactive,124511890.0,2655116.0,,CDPK4_IC50_uM,Biochemical screen of P. falciparum CDPK4,Confirmatory,26934697.0,
1800,1159589,1,2,,307068478,3213,Inactive,124803797.0,810694.0,,,Biochemical screen of P. falciparum MAPK2,Other,26934697.0,
1801,1159606,1,1,,56424143,3213,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1802,1159607,2,1,,312596481,3213,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1803,1169827,1,1,,103184924,3213,Active,,,37.92,IC50,Cytotoxicity against human KKU-M156 cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay,Confirmatory,25337628.0,
1804,1169828,1,1,,103184924,3213,Active,,,6.58,IC50,Cytotoxicity against human KKU-M213 cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay,Confirmatory,25337628.0,
1805,1169829,1,1,,103184924,3213,Active,,,18.27,IC50,Cytotoxicity against human KKU-M139 cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay,Confirmatory,25337628.0,
1806,1169830,1,1,,103184924,3213,Active,,,15.51,IC50,Cytotoxicity against african green monkey Vero cells assessed as growth inhibition after 24 hrs by sulforhodamine B assay,Confirmatory,25337628.0,
1807,1172695,1,2,,103184924,3213,Active,,,1.2,IC50,Cytotoxicity against human KB cells,Confirmatory,25442310.0,
1808,1172696,1,1,,103184924,3213,Active,,,1.2,IC50,Cytotoxicity against human HepG2 cells,Confirmatory,25442310.0,
1809,1172715,1,2,,103184924,3213,Active,,,0.00126,IC50,Cytotoxicity against human KB cells assessed as reduction in cell growth after 3 days by MTT assay,Confirmatory,25442315.0,
1810,1172716,1,1,,103184924,3213,Active,,,0.00126,IC50,Cytotoxicity against human HepG2 cells assessed as reduction in cell growth after 3 days by MTT assay,Confirmatory,25442315.0,
1811,1172717,1,1,,103184924,3213,Active,,,0.0018,IC50,Cytotoxicity against human Lu cells assessed as reduction in cell growth after 3 days by MTT assay,Confirmatory,25442315.0,
1812,1172718,1,1,,103184924,3213,Active,,,0.0021,IC50,Cytotoxicity against human MCF7 cells assessed as reduction in cell growth after 3 days by MTT assay,Confirmatory,25442315.0,
1813,1186145,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human HuCCa1 cells assessed as reduction in cell viability after 48 hrs by MTT assay,Confirmatory,25078311.0,
1814,1186146,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTT assay,Confirmatory,25078311.0,
1815,1186147,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay,Confirmatory,25078311.0,
1816,1186148,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human MOLT3 cells assessed as reduction in cell viability after 48 hrs by XTT assay,Confirmatory,25078311.0,
1817,1186149,1,1,,103184924,3213,Inconclusive,,,,IC50,Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 after 24 hrs by [3H]hypoxanthine incorporation assay,Confirmatory,25078311.0,
1818,1186150,1,1,,103184924,3213,Active,,,1.94,IC50,Cytotoxicity against african green monkey Vero cells assessed as reduction in cell viability after 4 days by green fluorescent protein detection method,Confirmatory,25078311.0,
1819,1207600,1,1,,103184924,3213,Unspecified,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,Other,,
1820,1207601,1,1,,103184924,3213,Unspecified,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,Other,,
1821,1207602,1,2,,103184924,3213,Unspecified,74959757.0,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,Other,,
1822,1224748,1,2,,103184924,3213,Unspecified,20178276.0,5563.0,,,Delta TM value showing the stabilisation of AMPKA2 produced by compound binding,Other,18077363.0,
1823,1224749,1,2,,103184924,3213,Unspecified,56404610.0,57118.0,,,Delta TM value showing the stabilisation of CAMK1D produced by compound binding,Other,18077363.0,
1824,1224750,1,2,,103184924,3213,Unspecified,73620970.0,57172.0,,,Delta TM value showing the stabilisation of CAMK1G produced by compound binding,Other,18077363.0,
1825,1224751,1,2,,103184924,3213,Unspecified,296434552.0,815.0,,,Delta TM value showing the stabilisation of CAMK2A produced by compound binding,Other,18077363.0,
1826,1224752,1,2,,103184924,3213,Unspecified,334302890.0,816.0,,,Delta TM value showing the stabilisation of CAMK2B produced by compound binding,Other,18077363.0,
1827,1224753,1,2,,103184924,3213,Unspecified,116242602.0,817.0,,,Delta TM value showing the stabilisation of CAMK2D produced by compound binding,Other,18077363.0,
1828,1224754,1,2,,103184924,3213,Unspecified,62512173.0,818.0,,,Delta TM value showing the stabilisation of CAMK2G produced by compound binding,Other,18077363.0,
1829,1224755,1,2,,103184924,3213,Unspecified,2499586.0,814.0,,,Delta TM value showing the stabilisation of CAMK4 produced by compound binding,Other,18077363.0,
1830,1224756,1,2,,103184924,3213,Unspecified,317373374.0,10645.0,,,Delta TM value showing the stabilisation of CAMKK2 produced by compound binding,Other,18077363.0,
1831,1224757,1,2,,103184924,3213,Unspecified,116051.0,1017.0,,,Delta TM value showing the stabilisation of CDK2 produced by compound binding,Other,18077363.0,
1832,1224758,1,2,,103184924,3213,Unspecified,266423.0,1021.0,,,Delta TM value showing the stabilisation of CDK6 produced by compound binding,Other,18077363.0,
1833,1224759,1,2,,103184924,3213,Unspecified,229463050.0,8814.0,,,Delta TM value showing the stabilisation of CDKL1 produced by compound binding,Other,18077363.0,
1834,1224760,1,2,,103184924,3213,Unspecified,6685284.0,11200.0,,,Delta TM value showing the stabilisation of CHEK2 produced by compound binding,Other,18077363.0,
1835,1224761,1,2,,103184924,3213,Unspecified,206729857.0,1195.0,,,Delta TM value showing the stabilisation of CLK1 produced by compound binding,Other,18077363.0,
1836,1224762,1,2,,103184924,3213,Unspecified,1705919.0,1196.0,,,Delta TM value showing the stabilisation of CLK2 produced by compound binding,Other,18077363.0,
1837,1224763,1,2,,103184924,3213,Unspecified,148887358.0,1198.0,,,Delta TM value showing the stabilisation of CLK3 produced by compound binding,Other,18077363.0,
1838,1224764,1,2,,103184924,3213,Unspecified,18202957.0,53944.0,,,Delta TM value showing the stabilisation of CK1G1 produced by compound binding,Other,18077363.0,
1839,1224765,1,2,,103184924,3213,Unspecified,3024060.0,1455.0,,,Delta TM value showing the stabilisation of CK1G2 produced by compound binding,Other,18077363.0,
1840,1224766,1,2,,103184924,3213,Unspecified,47117932.0,1456.0,,,Delta TM value showing the stabilisation of CK1G3 produced by compound binding,Other,18077363.0,
1841,1224767,1,2,,103184924,3213,Unspecified,38604691.0,1613.0,,,Delta TM value showing the stabilisation of DAPK3 produced by compound binding,Other,18077363.0,
1842,1224768,1,2,,103184924,3213,Unspecified,363548519.0,1760.0,,,Delta TM value showing the stabilisation of DMPK1 produced by compound binding,Other,18077363.0,
1843,1224769,1,2,,103184924,3213,Unspecified,20455502.0,2932.0,,,Delta TM value showing the stabilisation of GSK3B produced by compound binding,Other,18077363.0,
1844,1224770,1,2,,103184924,3213,Unspecified,215274013.0,3716.0,,,Delta TM value showing the stabilisation of JAK1~B produced by compound binding,Other,18077363.0,
1845,1224771,1,2,,103184924,3213,Unspecified,547915.0,5605.0,,,Delta TM value showing the stabilisation of MEK2 produced by compound binding,Other,18077363.0,
1846,1224772,1,2,,103184924,3213,Unspecified,1709088.0,5608.0,,,Delta TM value showing the stabilisation of MAP2K6 produced by compound binding,Other,18077363.0,
1847,1224773,1,2,,103184924,3213,Unspecified,6685617.0,4217.0,,,Delta TM value showing the stabilisation of ASK1 produced by compound binding,Other,18077363.0,
1848,1224774,1,2,,103184924,3213,Unspecified,134047835.0,5600.0,,,Delta TM value showing the stabilisation of p38beta produced by compound binding,Other,18077363.0,
1849,1224775,1,2,,103184924,3213,Unspecified,232066.0,5595.0,,,Delta TM value showing the stabilisation of ERK1 produced by compound binding,Other,18077363.0,
1850,1224776,1,2,,103184924,3213,Unspecified,2499596.0,5597.0,,,Delta TM value showing the stabilisation of ERK3 produced by compound binding,Other,18077363.0,
1851,1224777,1,2,,103184924,3213,Unspecified,73621232.0,51765.0,,,Delta TM value showing the stabilisation of MST4(1) produced by compound binding,Other,18077363.0,
1852,1224778,1,2,,103184924,3213,Unspecified,1709252.0,4751.0,,,Delta TM value showing the stabilisation of NEK2 produced by compound binding,Other,18077363.0,
1853,1224779,1,2,,103184924,3213,Unspecified,37537993.0,10783.0,,,Delta TM value showing the stabilisation of NEK6 produced by compound binding,Other,18077363.0,
1854,1224780,1,2,,103184924,3213,Unspecified,73621340.0,9943.0,,,Delta TM value showing the stabilisation of OSR1 produced by compound binding,Other,18077363.0,
1855,1224781,1,2,,103184924,3213,Unspecified,12585288.0,10298.0,,,Delta TM value showing the stabilisation of PAK4 produced by compound binding,Other,18077363.0,
1856,1224782,1,2,,103184924,3213,Unspecified,12585290.0,57144.0,,,Delta TM value showing the stabilisation of PAK5 produced by compound binding,Other,18077363.0,
1857,1224783,1,2,,103184924,3213,Unspecified,23396789.0,56924.0,,,Delta TM value showing the stabilisation of PAK6 produced by compound binding,Other,18077363.0,
1858,1224784,1,2,,103184924,3213,Unspecified,266425.0,5127.0,,,Delta TM value showing the stabilisation of PCTK1 produced by compound binding,Other,18077363.0,
1859,1224785,1,2,,103184924,3213,Unspecified,17380162.0,5170.0,,,Delta TM value showing the stabilisation of PDK1 produced by compound binding,Other,18077363.0,
1860,1224786,1,2,,103184924,3213,Unspecified,83305339.0,5292.0,,,Delta TM value showing the stabilisation of PIM1 produced by compound binding,Other,18077363.0,
1861,1224787,1,2,,103184924,3213,Unspecified,20139243.0,11040.0,,,Delta TM value showing the stabilisation of PIM2 produced by compound binding,Other,18077363.0,
1862,1224788,1,2,,103184924,3213,Unspecified,215274221.0,415116.0,,,Delta TM value showing the stabilisation of PIM3 produced by compound binding,Other,18077363.0,
1863,1224789,1,2,,103184924,3213,Unspecified,1709658.0,5347.0,,,Delta TM value showing the stabilisation of PLK1 produced by compound binding,Other,18077363.0,
1864,1224790,1,2,,103184924,3213,Unspecified,160113150.0,10733.0,,,Delta TM value showing the stabilisation of PLK4 produced by compound binding,Other,18077363.0,
1865,1224791,1,2,,103184924,3213,Unspecified,125205.0,5566.0,,,Delta TM value showing the stabilisation of PRKACA produced by compound binding,Other,18077363.0,
1866,1224792,1,2,,103184924,3213,Unspecified,143811448.0,55781.0,,,Delta TM value showing the stabilisation of RIOK2 produced by compound binding,Other,18077363.0,
1867,1224793,1,2,,103184924,3213,Unspecified,1730070.0,6197.0,,,Delta TM value showing the stabilisation of RSK2a produced by compound binding,Other,18077363.0,
1868,1224794,1,2,,103184924,3213,Unspecified,1730070.0,6197.0,,,Delta TM value showing the stabilisation of RSK2b produced by compound binding,Other,18077363.0,
1869,1224795,1,2,,103184924,3213,Unspecified,74762732.0,9748.0,,,Delta TM value showing the stabilisation of SLK produced by compound binding,Other,18077363.0,
1870,1224796,1,2,,103184924,3213,Unspecified,12643358.0,6793.0,,,Delta TM value showing the stabilisation of LOK produced by compound binding,Other,18077363.0,
1871,1224797,1,2,,103184924,3213,Unspecified,46577677.0,8576.0,,,Delta TM value showing the stabilisation of MPSK1 produced by compound binding,Other,18077363.0,
1872,1224798,1,2,,103184924,3213,Unspecified,317373279.0,9263.0,,,Delta TM value showing the stabilisation of DRAK1 produced by compound binding,Other,18077363.0,
1873,1224799,1,2,,103184924,3213,Unspecified,56749457.0,11329.0,,,Delta TM value showing the stabilisation of NDR1 produced by compound binding,Other,18077363.0,
1874,1224800,1,2,,103184924,3213,Unspecified,73621232.0,51765.0,,,Delta TM value showing the stabilisation of MST4 (2) produced by compound binding,Other,18077363.0,
1875,1224801,1,2,,103184924,3213,Unspecified,13124559.0,6789.0,,,Delta TM value showing the stabilisation of MST1 produced by compound binding,Other,18077363.0,
1876,1224802,1,2,,103184924,3213,Unspecified,29840818.0,23043.0,,,Delta TM value showing the stabilisation of TNIK produced by compound binding,Other,18077363.0,
1877,1224803,1,2,,103184924,3213,Unspecified,83305809.0,55872.0,,,Delta TM value showing the stabilisation of PBK produced by compound binding,Other,18077363.0,
1878,1224804,1,2,,103184924,3213,Unspecified,45593726.0,7443.0,,,Delta TM value showing the stabilisation of VRK1 produced by compound binding,Other,18077363.0,
1879,1224805,1,2,,103184924,3213,Unspecified,90116515.0,7444.0,,,Delta TM value showing the stabilisation of VRK2 produced by compound binding,Other,18077363.0,
1880,1224806,1,2,,103184924,3213,Unspecified,45593724.0,51231.0,,,Delta TM value showing the stabilisation of VRK3 produced by compound binding,Other,18077363.0,
1881,1224807,1,2,,103184924,3213,Inconclusive,12643529.0,10494.0,,,Delta TM value showing the stabilisation of YSK1 produced by compound binding,Other,18077363.0,
1882,1224817,1,1,,114695,3213,Active,,,,,Assays to identify small molecules inhibitory for eIF4E expression,Other,26144883.0,
1883,1224818,1,1,,312344656,3213,Inconclusive,,,21.1317,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway - cell viability counter screen,Confirmatory,,
1884,1224819,1,1,,312344656,3213,Inconclusive,325495545.0,2101.0,3.7578,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1885,1224820,1,1,,312344656,3213,Inactive,325495545.0,2101.0,3.3491,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway,Confirmatory,,
1886,1224821,1,1,,312344656,3213,Inconclusive,325495545.0,2101.0,3.7578,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1887,1224822,1,1,,312344656,3213,Inconclusive,,,10.5909,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) ### cell viability counter screen,Confirmatory,,
1888,1224823,1,1,,312344656,3213,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC),Confirmatory,,
1889,1224857,2,1,,312344656,3213,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1890,1224859,2,1,,90341166,3213,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1891,1224864,1,2,,316935291,3213,Inactive,,,,,HCS microscopy assay (F508del-CFTR),Screening,27732613.0,
1892,1224865,1,2,,56424143,3213,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1893,1224905,2,1,,121361347,3213,Inactive,120997.0,25643.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1894,1224905,2,1,,121361347,3213,Inactive,74356043.0,55704.0,,,High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i G protein subunits,Screening,,
1895,1227983,1,1,,103184924,3213,Active,,,1.98,IC50,Antiproliferative activity against human KB cells assessed as reduction in cell growth incubated at 37 degC for 3 days by resazurin microplate assay,Confirmatory,25734623.0,
1896,1227985,1,1,,103184924,3213,Active,,,3.8,IC50,Cytotoxicity against African green monkey Vero cells assessed as reduction in cell growth incubated at 37 degC for 4 days by fluorescence based assay,Confirmatory,25734623.0,
1897,1232934,1,1,,103184924,3213,Active,,,1.94,IC50,Cytotoxicity against african green monkey Vero cells after 4 days by green fluorescent protein detection method,Confirmatory,25934226.0,
1898,1238138,1,1,,103184924,3213,Active,,,2.72,IC50,Cytotoxic activity against human Lu1 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1899,1238139,1,1,,103184924,3213,Active,,,3.98,IC50,Cytotoxic activity against human KB cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1900,1238140,1,1,,103184924,3213,Active,,,3.21,IC50,Cytotoxic activity against human MDA-MB-231 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1901,1238141,1,1,,103184924,3213,Active,,,3.21,IC50,Cytotoxic activity against human LNCAP cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1902,1238142,1,1,,103184924,3213,Active,,,3.5,IC50,Cytotoxic activity against human HepG2 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1903,1238143,1,1,,103184924,3213,Active,,,3.82,IC50,Cytotoxic activity against human MKN7 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1904,1238144,1,1,,103184924,3213,Active,,,3.17,IC50,Cytotoxic activity against human SW480 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1905,1238145,1,1,,103184924,3213,Active,,,2.93,IC50,Cytotoxic activity against human HL60 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1906,1238146,1,1,,103184924,3213,Active,,,1.14,IC50,Cytotoxic activity against human SK-MEL-2 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1907,1238147,1,1,,103184924,3213,Active,,,1.26,IC50,Cytotoxic activity against mouse 3T3 cells assessed as inhibition of cell growth incubated for 48 hrs by SRB method,Confirmatory,26077495.0,
1908,1238174,1,1,,103184924,3213,Active,,,1.3,IC50,Cytotoxicity against human KB cells,Confirmatory,26081288.0,
1909,1238175,1,1,,103184924,3213,Active,,,1.3,IC50,Cytotoxicity against human HepG2 cells,Confirmatory,26081288.0,
1910,1238176,1,1,,103184924,3213,Active,,,1.8,IC50,Cytotoxicity against human MCF7 cells,Confirmatory,26081288.0,
1911,1238177,1,1,,103184924,3213,Active,,,2.2,IC50,Cytotoxicity against human Lu cells,Confirmatory,26081288.0,
1912,1238343,1,1,,103184924,3213,Active,,,1.99,IC50,Cytotoxicity against human LNCAP cells after 48 hrs by SRB assay,Confirmatory,26099533.0,
1913,1238344,1,1,,103184924,3213,Active,,,1.95,IC50,Cytotoxicity against human MCF7 cells after 48 hrs by SRB assay,Confirmatory,26099533.0,
1914,1238345,1,1,,103184924,3213,Active,,,2.07,IC50,Cytotoxicity against human KB cells after 48 hrs by SRB assay,Confirmatory,26099533.0,
1915,1238346,1,1,,103184924,3213,Active,,,1.71,IC50,Cytotoxicity against human HepG2 cells after 48 hrs by SRB assay,Confirmatory,26099533.0,
1916,1238347,1,1,,103184924,3213,Active,,,2.15,IC50,Cytotoxicity against human SK-MEL-2 cells after 48 hrs by SRB assay,Confirmatory,26099533.0,
1917,1252950,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against HuCCa1 cells after 48 hrs by MTT assay,Confirmatory,26397393.0,
1918,1252951,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay,Confirmatory,26397393.0,
1919,1252952,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human A549 cells after 48 hrs by MTT assay,Confirmatory,26397393.0,
1920,1252953,1,1,,103184924,3213,Inconclusive,,,,IC50,Cytotoxicity against human MOLT3 cells after 48 hrs by XTT assay,Confirmatory,26397393.0,
1921,1252954,1,1,,103184924,3213,Active,,,4.05,IC50,Cytotoxicity against African green monkey Vero cells after 4 days by GFP detection method,Confirmatory,26397393.0,
1922,1252955,1,1,,103184924,3213,Inconclusive,,,,IC50,Antimalarial activity against multidrug-resistant Plasmodium falciparum K1 infected in human erythrocytes after 48 hrs by [3H]hypoxanthine incorporation assay,Confirmatory,26397393.0,
1923,1253859,1,1,,103184924,3213,Unspecified,,,,,Antiproliferative activity against human Lu cells,Other,26459207.0,
1924,1253860,1,1,,103184924,3213,Unspecified,,,,,Antiproliferative activity against human HepG2 cells,Other,26459207.0,
1925,1253861,1,1,,103184924,3213,Unspecified,,,,,Antiproliferative activity against human MCF7 cells,Other,26459207.0,
1926,1253862,1,1,,103184924,3213,Unspecified,,,,,Antiproliferative activity against mouse P338 cells,Other,26459207.0,
1927,1253863,1,1,,103184924,3213,Unspecified,,,,,Antiproliferative activity against human SW480 cells,Other,26459207.0,
1928,1254813,1,1,,103184924,3213,Unspecified,13959709.0,7153.0,,,Inhibition of recombinant human topoisomerase 2alpha mediated decatenation using kDNA as substrate at 100 uM incubated for 30 mins by agarose gel electrophoresis,Other,26334499.0,
1929,1259309,1,1,,178126464,3213,Active,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
1930,1259310,1,1,,332877144,3213,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1931,1259310,1,1,,332877499,3213,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1932,1259311,1,1,,178126464,3213,Active,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
1933,1259313,1,1,,56424143,3213,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1934,1259354,1,1,,348407169,3213,Inconclusive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
1935,1259370,2,2,,124634338,3213,Active,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1936,1259370,2,2,,124634338,3213,Active,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1937,1259370,2,2,,124634338,3213,Active,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
1938,1259389,1,1,,124634338,3213,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1939,1259407,1,1,,363899953,3213,Active,,,,,CCRIS mutagenicity studies,Other,,
1940,1259408,1,1,,363895676,3213,Active,,,,,GENE-TOX mutagenicity studies,Other,,
1941,1259409,1,1,,363899953,3213,Unspecified,,,,,CCRIS tumor inhibitor studies,Other,,
1942,1259416,1,2,,56424143,3213,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1943,1259416,1,2,,99432307,3213,Active,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1944,1259421,1,1,,99432307,3213,Active,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1945,1259423,1,2,,354748934,3213,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1946,1259423,1,2,,354910295,3213,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
